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DEDICATION

I dedicate this to you, Reader. If you are reading this, it is likely that you are
family, friends, colleagues, researchers, or someone who is curious about the world we
live in. The foundation of studying science is that we rely on each other. We use peer
review; we train those that don’t have experience; we advance science based on what
was discovered before us. For those of you reading this that are not chemists or
professional scientists, this is for you as well. Science is not for a certain sect of society.
It is for everyone, and we all benefit from the curiosity of others. Your enthusiasm for
learning more about the world around you is the same reason I remained motivated to
complete this degree. If you have need of the information within this dissertation, I
hope it helps you. We live in a world we must share, and I would like to share this
contribution with you.
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ABSTRACT

Despite its relatively low concentration in the human body, copper is an essential
transition metal ion. Under normal circumstances, it is a well-regulated trace element
that is introduced via diet or environment depending on the organism. Its strong
reactivity and binding to some biologically essential chemicals can be detrimental to the
host organism. Herein the oxidative chemistry of copper and its possible prevention in
humans and agricultural organisms is discussed, as well as the potential avenues as
metal-targeting disease treatment via novel-peptide and peptoid products.
In the first study, copper is implicated in the progression and onset of
Alzheimer’s disease. In this study I show a chemical that is found in beetroot, betanin,
can bind to the copper-amyloid beta complex, the complex implicated in AD, using
paramagnetic NMR techniques. Betanin also shows a reduction in catechol oxidase-like
activity of CuAβ towards DTBC under oxidative and peroxidative conditions with a Kic
and Kiu in the presence of ambient of O2 of 1.11 ± 0.03 and 2.2 ± 0.4 μM, respectively.
Betanin also showed inhibition towards H2O2-mediated CuAβ oxidation with a Kic and
Kiu of 0.76 ± 0.04 and 1.28 ± 0.08 μM, respectively.
Secondly, the potential activity of copper from an agricultural perspective is
presented where copper-bound bacitracin from the soil bacteria Bacillus subtilus is
xv

inhibited by natural products that may occur in the environment. Natural and synthetic
metal-binding oxidative inhibitors, salicylic acid and thiabendazole, respectively, were
chosen based on the potential interaction with CuBc based on their place in medicine
and/or the environment around plants. Paramagnetic NMR techniques show each
compound can form the ternary complex with CuBc and the subsequent inhibition of
redox activity. Salicylic acid of the willow tree showed inhibition constants of Kic,O2 of
5.24 ± 0.03 mM, Kiu,O2 of 21 ± 3 mM, and a Kiu,H2O2 15 ± 3 μM. Thiabendazole revealed
inhibition constants of Kic,O2 of 1.1 ± 0.4 mM, Kiu,O2 of 1.5 ± mM, Kic,H2O2 6.3 ± 0.7 μM,
and Kic,H2O2 of 13.2 ± 2.6 μM.
In the last chapter a novel γ-AApeptide right-handed helical “foldamer” and the
structure of a similar γ-AApeptide were examined. Peptoids are a type of
peptidomimetic compound that is synthesized with the α-carbon sidechain substituted
onto the nitrogen on the peptide backbone. One of the key advantages in using peptoids
is their increase in bioavailability given the inability to be metabolized by proteases. The
first half of this study uses NMR techniques to support the structural information about
a novel γ-AApeptide. The examination of incorporating metals into these novel
peptides in the second half of the study would help elucidate the role of metals as they
are often under-utilized in drugs or drug targets. This study shows the differences in
binding resulting in a difference in metal binding as well as a difference in reactivity.

xvi

CHAPTER 1: INTRODUCTION

Life Is So Metal: A Survey of Copper-Peptide Interactions in Life, Disease, and
Disease Treatment from Humans to Agriculture

Because the history of evolution is that life escapes all barriers. Life breaks free. Life expands to
new territories. Painfully, perhaps even dangerously. But life finds a way.
- Jurassic Park by Michael Crichton

I.

A Very Brief History and Introduction of Metals in Biology

Metals have an undeniable role in life and biology as we know it. The oxygen all
aerobic organisms breathe was formed in the chloroplast of plants using copper in
plastocyanin to transport electrons. Those electrons are bound for manganese clusters
responsible for the formation of O2 from water and carbon dioxide. That dioxygen
might then eventually be bound for the lungs of an aerobic organisms that uses iron in
hemoglobin to bond to and transport the O2 to the proper muscle or organ. The example
of using metals in respiration is only a very small fraction how biological systems uses
transition metals for essential biological purposes. Their role in biology is complexly
1

interwoven with basic function of the organism, and their dysregulation are implicated
in a number of diseases.
The history of metals in biology is intricately linked to the presence of
atmospheric and dissolved oxygen concentrations. For billions of years early life
developed under reductive conditions largely due to the low concentration of oxygen in
the atmosphere (<0.001% of current levels) and oceans, making metals relatively
inactive and insoluble in their reduced states.1 “Great oxygenation or oxidation events”
that occurred around 2.5 billion years ago eventually raised the oxygen content to ~20%
of the current atmospheric composition, which caused mass extinctions of the mainly
anaerobic life.2 These early lifeforms did not have the molecular and physiological
capacity to manage the reactivity of molecular oxygen and ambient oxidized
compounds like transition metals; O2 was effectively a poison to most early life.3-5 The
organisms that adapted in the harsh oxidative environment were those that could
reduce the toxicity of O2 or developed the means to reduce it. Many of these organisms
not only found a means to prevent toxicity, within limits, but developed means to
incorporate O2 into biological functions that use it as an electron acceptor in the
eventual production of ATP.6 Many of these systems that developed under aerobic
conditions actually lead to a more efficient means of producing nearly 15 to 20 times
more ATP! And many of them that evolved during this time period of an oxygen boom
involved metals, the most prominent of which involved iron, given its several easily
accessible oxidation states and high crust and oceanic concentrations compared to other
2

metals. The relative distribution of most common transition metals are constant
between the soil, ocean, and higher organisms as shown in Figure 1.1. Many of the
reactions discussed herein are between a copper ion, a reduced form of oxygen, and an
O2 molecule; and their associations in life are as old as life itself.

Log mass composition
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Figure 1.1 - Comparison of chemical distribution of the most common inorganic
elements in earth’s crust, oceans, and of an average 80.7 kg human body. Data adapted
with permission from CRC Handbook of Chemistry and Physics.7,8

Still, the role of metal in biology is diverse beyond its interaction with molecular
oxygen. Copper(II) and iron(III) may have played an essential role in the formation of
early amino acids by lowering the activation energy required to perform the
condensation reaction to form peptide bonds.9,10 Transition metals can also aid in
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maintaining protein structure, such as the zinc-finger motif, by acting as a binding site
for dioxygen transport, like copper in the hemocyanin of mollusks, or by playing an
active role in the chemistry of the enzyme, such as molybdenum and iron in nitrogenase
for reducing N2 to ammonia in nitrogen-fixation bacteria, such as Azotobacteria.11-13
Despite their relatively low concentrations in the environment compared to organic
compounds, metals are estimated to be associated with approximately one-third of all
proteins. Iron, zinc, and copper comprise a majority of the transition metals in biology,
however, many of the other transition metals, such as cobalt, nickel, manganese, and
vanadium, can be found in trace or ultra-trace amounts in many biological systems.14 In
fact, the deficiency of any of these metals can lead to health problems that include
anemia, heart disease, and slowed growth of many organisms and microorganisms. In a
recent story that made headlines, a “fussy” eating teenager that went blind and started
to lose hearing was found to have dangerously low levels of iron, copper, selenium, and
vitamin B12, a cobalt-bound cofactor!15
Dysregulation of homeostatic regulation of redox-active metals can lead to the
formation of free-radicals and reactive oxidative species (ROS). Biologically, ROS are
most commonly chemical byproducts of mitochondrial reactions with O2. The
production of reactive oxidative species (ROS) is not inherently detrimental as some
research has shown some ROS might also be used as messenger molecules for calcium
regulation or in the chemical pathway triggering cell apoptosis.16,17 The need for strict
regulation is essential, though, as dysregulation is implicated in a number of
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diseases!18,19 Some of the most efficient enzymes in nature are those that deal with
quenching the presence or production of reactive oxidative species (ROS), such as
superoxide (O2—), peroxide (O22—), and hydroxyl radicals (•OH), given their strong and
non-specific reactions with biomolecules. The sources of ROS can be endogenous,
especially from the mitochondrial electron transport, and exogenous sources such as
ionizing radiation from X-ray and ultraviolet radiations, and environmental toxins.20
The reduction of O2 to superoxide can occur biologically in mitochondrial complexes I
and III (Reaction 1.1).21

O2 + e— → O2—•

Reaction 1.1

Accumulation of superoxide can in turn generate another ROS molecule hydrogen
peroxide via disproportionation (Reaction 1.2). This is also often mediated by enzyme
superoxide dismutase in regulation of superoxide ions.

2 O2— + e— + 2H+ → H2O2 + O2

Reaction 1.2

Further generation of ROS hydroxyl radical, •OH, is produced via disproportionation
of hydrogen peroxide (Reactions 1.3 and 1.4). Catalases and peroxidases can mediate
the radical generation by converting hydrogen peroxide to water.
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H2O2 + e— + H+ → H2O + •OH

Reaction 1.3

•OH + e— + H+ → H2O

Reaction 1.4

From the metal perspective reactive oxygen can be produced by a reduced form
of metal, such as Fe2+ or Cu+ ions, overcoming the initial energy required to
spontaneously oxidize:

O2 + Cu+ ↔ O2•— + Cu2+

Reaction 1.5

Additionally, Cu+ can further react in a Fenton-like reaction generating a hydroxyl
radical (Reaction 1.6):

Cu+ + H2O2 ↔ Cu2+ + OH— + OH•

Reaction 1.6

Metal reactions with O2•- can also form the highly reactive singlet oxygen, 1O2. .
While most biological systems contain enzymes that remove free-radicals to prevent
immediate harm, such as the aforementioned superoxide dismutase and catalase,
accumulation of small amounts of oxidation can lead to disease, discussed in more
detail in subsequent sections.
Generally, ROS react with biological compounds without specificity. This can
lead to a number complication in biological functions as they readily react with
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proteins, DNA, lipids and more! Eventually, these reactions can lead to
neurodegenerative diseases, cancer, aging and others.22 Metals in biology can play a
role in both the generation of oxidative stress and quenching ROS activity. Enzymes like
superoxide dismutase and glutathione peroxidase can protect against ROS activity
using metal centers to catalyze their reduction.
The main transition metal explored in this dissertation is copper. Despite
composing around 1/100,000 of a human body’s mass composition, it is an essential
metal that performs all of the aforementioned roles metals can play in biology, and does
so in all known forms of life to some extent, even with limited use in anaerobic
bacteria.23-25 Herein, the investigation of a few metal-binding biomolecules are
discussed for better understanding of copper in biology as well as its role in
neurodegenerative diseases and how some organisms have adapted to the use of
copper and prevent oxidative damage caused by copper.

II.

Copper in Biology

The role of copper in biological systems, its role in disease, and some of the
topics relevant to studies in subsequent chapters are subsequently discussed. The
relatively low concentration of copper in biology should not understate its role in those
systems. Copper is found in the active center of numerous essential enzymes in the
body.
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The preferred binding motifs for copper in biological systems tends to rely on the
oxidation state of the ion and the electron charge distribution of the ligand. The most
common oxidation states for copper are the +1 and +2 states, typically with a 3d9
paramagnetic electron valence. Copper(II) often forms octahedral geometries, which can
sometimes elongate along the dz2 orbital through the Jahn-Teller effect. There are a few
proposed examples of Cu3+, however, they are much rarer than their mono- and
divalent counterparts, and have yet to be recorded in biological systems. The reduced
state Cu1+ tends to coordinate to sulfur-based compounds like cysteine and methionine.
Loss of an electron due to oxidation of a substrate or a ligand forms Cu2+, which tends
to bind more frequently to oxygen- or nitrogen-containing residues in biological
systems. Changes in binding affinity based on charge state of the ion tends to change
distances between the metal and the ligand, as well as altering the ligand field
stabilization energy (LFSE).

2. Copper Proteins

The common forms of ionic copper, Cu1+/2+, can have highly reactive electron
configurations. Biological systems evolved around these highly reactive ions, using
them to perform many functions in biological systems, often modulating the reactivity
by altering the active site accessibility or ligand interaction. The overall functionality of
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copper is typically found within a few biologically well-conserved binding motifs or
reaction profiles in proteins classified as types I, II, or III copper proteins.

2.1. Type I Copper Proteins

Type 1 copper proteins can be found in many different types of biological
systems, from plants to bacteria. Some of the prototypical blue copper proteins can be
found in electron transport chain in plant plastocyanin and the azurin proteins found in
bacteria.
Type I copper proteins, also known as blue copper proteins or cupredoxins, are
typically distinguished by a pseudo-tetrahedral coordination site consisting of two
histidine residues bound at the imidazole Nδ atom, a cysteine sulfur, and a methionine
residue within the protein. As their colloquial name suggests, these proteins have an
intense blue color that absorbs light at around 600 nm with an absorptivity as high as
6000 M—1 cm—1 that is derived from the ligand-to-metal charge transfer transition from
the S of the coordination cysteine residue to the Cu2+ ion with the cysteine residue.

2.1.1. Plastocyanin

The quintessential type I copper protein studied is plastocyanin. It functions, like
other blue copper proteins, as an electron transfer protein. In plastocyanin, copper(II) is
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reduced to copper(I) by cytochrome b6f, wherein the copper(I) is oxidized by
cytochrome P700 in the photosystem I process.

Cytf• + PCCu2+ → Cytf + Cu1+

Reaction 1.7

PCCu1+ + P700+ → PCCu2+ + P700

Reaction 1.8

The copper ion resides in a distorted 4-coordinated tetrahedral geometry of a cysteine
and two histidine residues, and typically a methionine residue. Similar type I copper
the axially-coordinated methionine residue can vary based on the protein with
glutamine, valine, leucine, or phenylalanine.26 The coordinating ligands cysteine and
methionine have unusual bond distances with the oxidized copper ion of ~2.0 and 2.8
Å, respectively.27 The binding geometry around the copper active site is relatively rigid
with only minor geometric changes during redox reactions. The rigid distorted
tetrahedral geometry is not an ideal geometry for both Cu2+ and Cu1+, which is
exemplified by the small ~0.7 eV reorganization energy of the relatively rigid
coordination structure. Small reorganization energy allows for fast electron transfer.
Modulating the electron transfer reaction is a combination of protein-protein surface
interactions based on hydrophobicity and hydrophilicity of the amino acid residues,
pH-dependent gating, and small changes in the coordination environment around the
metal.26 Cyrstallographic data revealed bond distance and geometric changes of His-44
and Gln-95 of umecyanin during redox cycling of the metal center. These residues
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would be analogous His-44 and Met-92, respectively, in plastocyanin. The study found
a more trigonal pyramidal geometry in the Cu1+ ion as bond distances increased for
His-44 and Gln-95. This is likely due to structural changes due to protein-protein
interactions.28

Figure 1.2 - Plastocyanin (PDB: 2PCF) Spinacia oleracea with focus on the copper active
site and its ligands on the right29

Like most things in life, there are always exceptions to the rule. Not all type I
copper proteins are exactly the same, nor would they be based on differences in
environmental pressures that lead to the protein as it exists in its respective system. In
stellacyanin, the methionine residue is replaced by glutamine and shows a shorter Cu-
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OGln bond distance at 2.2 Å than the Cu-Smet compared to 2.8 Å in plastocyanin,
stabilized by a more tetrahedral geometry and solvent exposure.30

2.2. Type II Copper Proteins

Type II copper proteins, similar to type I copper proteins, are also mononuclear
copper proteins, though, they tend to have a distorted 5-coordination planar geometry
at the copper center. Unlike the electron-rich environment from the sulfur ligands,
cysteine and methionine in Type I copper proteins, type II copper proteins have various
coordination ligands that are typically a combination of histidine, aspartate/glutamate,
and tyrosine. The functionality of type II copper proteins is varied, ranging from
dioxygen transport and catalysis, to ROS quenching, and nitrogen assimilation with
nitrite reductase in plants, to name a few.31 The overall function can be summed up for
their ability to reduce their substrates. The following type II copper proteins are some of
the quintessential type II proteins, which only represents some of the functions of all
type II copper proteins.32

2.2.1. Cu,Zn Superoxide Dismutase (SOD1)

Cu,Zn-containing SOD (Cu,Zn-SOD or SOD1) is probably one of the most wellstudied type II copper proteins, if not the most studied copper protein in general other
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than potentially plastocyanin. Its primary role in biological systems is to quench
superoxide, a byproduct produced during cycles involved in aerobic respiration and
photosynthesis. The importance of SOD1 in biological systems cannot be understated as
mutations or down-regulation of SOD1 transcription is implicated in many types of
cancers, neurological diseases like ALS (discussed in more detail in section 3.2), and
other age-related diseases.33,34 At the molecular scale, ROS, such as hydrogen peroxide
(H2O2) or superoxide (O2—), are indiscriminate in their reactions with DNA,
carbohydrates, fatty acids, lipids, and many other molecules relevant to a living system,
indicating the importance of Cu,ZnSOD in health and disease regulation.
The general reactions, in a ping-pong mechanism, that SOD1 can perform are

(1) O2- + Cu2+ZnSOD → O2 + Cu1+ZnSOD

Reaction 1.9

(2) O2- + Cu1+ZnSOD +2H+ → H2O2 + Cu2+ZnSOD

Reaction 1.10

These reactions occur with an efficiency of 2-6 × 109 M—1 sec—1, a diffusion limited
reaction!35,36
There are four different kinds of SOD with an active site that can contain iron,
manganese, nickel, or zinc and copper. The most common type in eukaryotes is the
Cu,ZnSOD.37 The coordination sphere of SOD proteins is comprised of three or four
histidine residues (dependent on oxidation state). The 4 histidine residues typically
form a distorted square planar geometry around the copper(II) active site. Unlike most
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of the other enzymes discussed, SOD1 is a dimetallic enzyme as shown in Figure 1.3.
One of the histidine amino acids that is coordinated to the copper active site is also
coordinated to a zinc ion, confirmed by a number of crystallographic and NMR studies.
The bridging histidine is currently known to be unique to Cu,ZnSOD. Reduction of the
bridging imidazolate and copper center leads breaking the coordination between the
two metal cations, thus forming a distorted trigonal planar geometry.38 The
coordination of oxidized form of copper in the active site when bound to all four
histidine residues yields a primary absorption band at 680 nm with an absorptivity of
155 M—1 cm—1.

Figure 1.3 - PDB ID: 3MND. Oxidized form of Cu,Zn superoxide dismutase enzyme
(left) and the active site of copper (orange) and zinc (right)39
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The bridging His-63 and the stabilizing zinc ion regulate the electron density
around the copper ion as it undergoes oxidation and reduction. EPR studies confirm
this geometry with g-values corresponding to a dx2-y2 orbital as the partially occupied
magnetic orbital (g|| > g⊥ > 2.0023), allowing for molecular oxygen binding to the dz2
orbital at the axial position.40
Interestingly, the role of zinc seems to be more structural than acting in any of
the chemistry. In fact, replacing zinc with other divalent metal ions has little effect on
the overall chemistry of SOD.41

2.2.2. Galactose Oxidase

Another example of a prototypical type-2 copper protein, to show the diversity of
this type of copper protein, is galactose oxidase. Discovered in 1959 galactose oxidase is
a ~68 kDa metallo-enzyme that is produced by Fusarium fungi.42
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Figure 1.4 – PDB ID: 2EIE galactose oxidase (left) with emphasis on the copper active
site (right).43

As part of the oxidoreductase family of enzymes, galactose oxidase catalyzes
oxidation of the C6 hydroxyl on D-galactose and galactoside, and other primary
alcohols. The generalized reaction is the oxidation of alcohol in galactose or galactoside
to form an aldehyde in the presence of O2 in a two electron transfer process as part of a
likely ping-pong mechanism:

D-Galactoside
Figure 1.5 – Oxidation of D-galactoside catalyzed by galactose oxidase and O2
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The coordination of galactose oxidase is dependent on the oxidation state of the
metal and the geometry of the binding pocket. The oxidized copper complex consists of
two tyrosine and two histidine residues, along with a solvent molecule to form a
distorted square pyramidal geometry. Upon reduction Cu+ yields a trigonal planar,
three-coordinated copper center by dissociating from Tyr495 and the solvent, confirmed
by X-ray absorbance techniques.44
One of the most interesting parts of the enzyme that attracts many researchers is
the fact that the copper center is attached to a stable radical in the tyrosine.45 The radical
tyrosine residue is stabilized in part by the post-translational cross-linkage of its ring to
the adjacent cysteine residue, forming a thioether bond (Figure 1.4, right panel).46
Moreover, it is proposed that the free-radical tyrosine plays a role in the two electron
transfer process given that Cu2+ can only facilitate a one-electron transfer reaction on its
own.

Figure 1.6 – a proposed simplified reaction mechanism for the redox reaction at the
copper center of galactose oxidase.
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In the above mechanism, initial electron transfer to form the aldehyde from the
alcohol takes place at the copper center, reducing Cu2+ to Cu1+. The fast nature of the
radical single electron transfer and the nearly diffusion limited turnover of molecular
oxygen make some of the smaller steps more difficult to propose for a more detailed
mechanistic analysis. Many of the mechanistic approaches used in research currently
uses models and computation to propose or support certain mechanisms of electron
and proton transfer.47,48 The D-galactose turnover efficiency has been shown to be 0.93 ×
104 M—1 s—1 and the molecular oxygen turnover efficiency at a near diffusion limitation
of 0.98 × 106 M—1 s—1 at pH 7.0. The galactoside methyl-α-D-galactopyranoside shows a
more favorable reaction with a catalytic efficiency of 1.53 × 104 M—1 s—1 and a
subsequent oxygen catalytic efficiency of 7.99 × 106 M—1 s—1.49,50 While these values vary
between species, these studies have shown the efficiency for O2 and
galactose/galactoside turnover by GO.

2.3. Type III Copper Proteins

The third type of copper protein discussed is the type 3 copper protein. These
proteins can be found in all domains of life on Earth!51 The key differentiation between
type 3 and copper protein types 1 and 2 is the di-copper center active site in type 3
proteins. Each copper ion in the active center is typically bound to the protein via three
histidine residues. The most common and well-studied of the type 3 copper proteins are
18

likely tyrosinase, catechol oxidase and hemocyanin (the blue molluscan functional
analogue of hemoglobin). The relation among the three most common type 3 copper
proteins goes all the way into the DNA, showing high conservation of binding motifs
on one of the coppers centers. It appears that the divergence of the second copper’s
binding pocket leads to a difference in substrate specificity, where the changes in the
binding pocket on the second copper cation modulate substrate specificity.55 They are
generally involved in activation or transportation of O2, or the hydroxylation of
monophenols for tyrosinase, often forming a side-on dioxygen bridge during the redox
reaction.

2.3.1. Catechol Oxidase

Of the many type 3 copper proteins, catechol oxidase is briefly reviewed here for its
relevance towards the activity observed in the subsequent chapters. Despite its presence
in a variety of life, plant polyphenol oxidase, a type of catechol oxidase, is the
predominant source of the protein in research. The size of the protein varies from
species to species, ranging ~38-42 kDa based on submitted PDB structures.52 As their
name suggests, catechol oxidase oxidizes catechols to form quinones. Most people are
aware of its effects after leaving an apple or banana on the counter too long. Fruits and
plants have many catechols and polyphenols that can be oxidized by catechol oxidase
and the analogous polyphenol oxidase. The accumulation of yellow ortho-quinone
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polymerizes into the brown-color polymers associated with an apple left out for too
long as catechols and polyphenols are oxidized by the enzyme with ambient O2.53

Catechol

o-Quinone

Figure 1.7 – oxidation of DTBC to form o-quinone product

The binding pocket of catechol oxidase is conserved in the typical type 3 binding
center: two coppers bound by three histidine residues on each metal as seen below.

Figure 1.8 – PDB ID: 2P3X Catechol oxidase with a focus on the di-copper active site,
with a ~45° horizontal rotation in the final frame for better visualization of the binding
pocket histidine residues54
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In the mechanistic cycle for catechol oxidase, the Cu-Cu bond distance is modulated
by the ligand bound to one or both, though, they can vary based on species as the
surrounding scaffold can affect metal-metal distance. The two most studied forms of
type 3 proteins are the met and oxy forms, seen below, where hydroxide or molecular
oxygen are bridges between the two coppers, respectively.

met form

deoxy (reduced) form

oxy form

Figure 1.9 – abbreviated catechol oxidase mechanism, showing key mechanistic
structures

In one of the well-studied catechol oxidases from Ipomoea batata (sweet potatoes) the CuCu distances are 2.9 Å in the met form and 4.4 Å in the oxy form.55 EXAFS methods
revealed the side-on μ-η2-η2 bonding of peroxide bridging the two copper(II) ions. The
distance between the two copper cations was found to be essential in model studies;
kinetic data indicates it likely loses it di-copper activity becoming two separate monocopper active sites as the distances increase to >5 Å.56
The fascinating di-copper and bridging dioxygen has led to some in-depth studies
on the electronic transitions as well. Electronic transitions at ~345 nm and ~580 nm
showed relatively strong absorbances with absorptivities of 20,000 M-1 cm-1 and 1,000
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M-1 cm-1, respectively. The strong charge transfer at ~345 nm is due to charge transfer
from the πσ* of O22— to dx2-y2 of Cu2+. The less intense band at ~580 nm is due to the
transition from the πυ* in O22— to dx2-y2 of Cu2+.57

III.

Role of Copper in Neurodegenerative Disease

Despite 2 billion years to adapt to the toxicity of redox activity of oxygen and
various biologically relevant metals, their dysregulation is still the source of toxicity,
exemplified in numerous diseases caused by oxidative stress. The strong reactivity of
most transition metals provide intense environmental pressures on biological systems
on the evolutionary scale, making their integration into a larger protein structure a
necessity for protection from these redox potentially harmful reactions. Dysregulation
of metals in in vivo can lead to myriad health issues, such as several implications in
cancer development, Creutzfeld-Jacob syndrome, Alzheimer’s disease, and
amyotrophic lateral sclerosis. Research in neurodegenerative disease, often shows the
presence of or mis-regulation of copper, among other metals, such as Fe+2/+3 and Zn2+.
Research in neurodegenerative diseases still leaves much to be concluded. Many
research articles that discuss any role of metal in disease will often use modifiers like
“might”, “could”, implicated”, “probable”, or “likely” because the pathway of disease
development is often not completely understood. Unlike diseases caused by viruses and
bacteria where diagnostics can be performed with some reliability and with well22

understood etiology, neurodegenerative diseases are more subtle. These diseases often
take years to develop where low levels of dysregulation accumulate over the course of
decades! As chemical and clinical studies continue to develop, the picture fills in littleby-little giving us more insights into how the diseases function and how they develop
in hopes that they can one day be reliably prevented treated.

3.1. Alzheimer’s Disease

The marvel of modern medicine has allowed humans to live longer, healthier
lives than they ever have in history. Survey data from the Centers for Disease Control
reveals the current average life expectancy to be approaching 80 years old, and an
upward trend in age is anticipated to continue!58 Studies in the last decade show the
most common cause of death, heart disease, has been in decline for nearly 50 years,
while age-related neurodegenerative disorders continue to rise.59-61 One of the key
challenges that an aging population creates is the growth of age-related disease
incidences, such as Alzheimer’s disease and Parkinson’s disease.62,63 Currently, the most
common neurodegenerative disorder is Alzheimer’s disease, affecting 10% of the
American population over the age of 65 and placing a $300 billion burden on both
suffers and taxpayers.58
Like most age-related diseases, the generalized causes are varied, with
implications towards environmental and genetic factors. The environmental factors that
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can impact the propensity to develop the disease are the some of the usual suspects: airquality, water quality, sedentary lifestyles, excessive alcohol consumption, etc.64-66 A
high-impact study by Saunders, et al. (cited nearly 4000 times at this writing!) found a
genetic link between late-onset AD and the ApoE ε4 allele, opposed to the protecting ε2
allele. Most people, though, have the ε3 allele which does not seem to play much of a
role in the disease.67 The current hypothesis toward the role of ApoE ε4 influence is that
it potentially upregulates γ-secretase, an enzyme involved in producing a peptide
implicated in AD, amyloid β (Aβ), from its precursor protein.68 In a related idea, one of
the leading ideas on copper’s involvement in Alzheimer’s disease is based on causing
aggregation of the 40 to 42 amino acid long Aβ peptide on brain tissue. Along with the
tau protein, aggregates of the amyloid beta peptide have been found on the brain tissue
of deceased AD patients in post-mortem observations. Moreover, these plaques were
found to have higher than normal amounts of iron, zinc, and copper.69 It is thought that
the aggregation of the peptide on brain tissue induces inflammation of brain tissue
which can trigger apoptosis. In a similar but alternative proposal, there is also research
indicating that apoptosis might also be triggered by Aβ interaction with a 17hydroxysteroid dehydrogenase 10, 17β-HSD10, an alcohol dehydrogenase in
mitochondria, creating toxic conditions that induce cell death.70 Loss of brain tissue
pockets then consequently leads to loss in memory and other mental faculties.
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Figure 1.10 – “Healthy Brain and Severe AD Brain” by National Institutes of Health.
CC-BY-NC.2.0 2016 by Copyright Holder.

More in-depth associations of copper in the disease, such as peptide-copper
structure and neurotoxic chemistry are covered in chapter 2. The propensity for the
disease is also not understood well as it seems genetics and lifestyle might both play a
role. Dysregulation of the amyloid protein or copper transport proteins, such as
ceruloplasmin, due to genetic disorders could both play a role in the disease.71
Similarly, poor diet or excess intake of biological metals could slowly trigger the
aggregate cascade.72,73

3.2. Amyotrophic Lateral Sclerosis

Dysregulation of the aforementioned copper protein SOD1 is also implicated in
amyotrophic lateral sclerosis (ALS), another neurological disorder, also known as Lou
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Gehrig’s disease. The disease presents in the slow loss of motor control as brain tissue
associated with motor neurons undergo apoptosis. The loss of motor control eventually
leads to paralysis and death due to organ failure for organs reliant on muscle function,
like the respiratory system. ALS is considered a rare disease with around 15,000 people
in the U.S. diagnosed, typically diagnosed after the age of 55 years.74 Though symptoms
had been observed prior to its official discovery; the first published recognition of ALS
occurred by Jean-Martin Charcot in 1874.75 Despite its rarity, it has been brought to
public awareness by celebrities like Lou Gehrig and Dr. Stephen Hawking having the
disease, as well as the viral Facebook “ice bucket challenge” that raised a substantial
amount of money towards its research.
The cause(s) of ALS are still not well-understood. Only 10% of those that suffer from
the disease have a family history of ALS, though, more current research is beginning to
recognize a link between ALS and other familial instances of neurodegenerative
diseases.76,77 A 2015 review found over 25 genes and hundreds of single-point
mutations implicated in the familial form ALS. Some of the genes show mutation for
SOD1 and mitochondrial myopathy resulting in an increase in ROS activity and
subsequent oxidative stress. Unfortunately, the genes implicated in familial ALS will
correlate to <5% of all ALS occurrences, implying both the complexity of the genetics
behind ALS and the role sporadic factors might play in its development.78
The genes for SOD1 regulation are implicated in up to ~20% of familial (nonsporadic) ALS cases. 78-80 Similar to Alzheimer’s disease, ALS has shown protein
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aggregation on neuronal tissue, often a mutant of SOD1, for familial-type ALS. Research
has revealed more than hundred mutations of SOD1 implicated in ALS, supporting its
importance in neuronal health! Therein the most common mutation of the SOD1 allele
is the D90A mutation, where the 90th codon for SOD1 is mutated from aspartic acid to
alanine.81 The loss of hydrogen-bonding from the aspartic acid causes structural
instability due to the change in polarity from the hydrophilic residue being replaced the
hydrophobic mutant residue.
Several other mutations for the SOD1 gene can cause subsequent amino acid
changes upon translation that can also affect SOD1 functionality. In U.S. populations
Ala4Val (alanine to valine mutation at codon 4) mutations of SOD1 is the most common
and often has less than a two year survivability on average.82 Studies observed lower
Km values (comparatively larger association of the H2O2-SOD1 complex) for H2O2
product relative to the wild-type protein, thus producing more free radical activity.83 In
the Gly93Ala mutant of SOD1 can lead to oxidative damage of the protein,
oligomerization, and eventual aggregation.84,85 As stated previously, hundreds of
genetic point mutation can lead to many SOD1 mutations that are implicated in ALS.
The role of all the mutations is still not fully understood, but case studies on some
specific mutations associated with aggregates have revealed loss of proper SOD
function and mis-folding around the metal center.86
Unfortunately, the role environmental factors play is not well-understood and seems
to be contingent on the health of some protective genes and proteins. Research has
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examined the effects of heavy metals, viruses, and factors that can induce oxidative
stress, all potentially showing some correlation with certain types of sporadic cases.87-89
Cases like SOD1 gene mutations provide at least some clues that might lead towards
treatment in the future.

IV.

Metallo-Antibiotics

Metallo-drugs, as whole, are an incredibly diverse and effective method for treating
disease. Some of the most effective and enduring metallo-drugs on the market are:

1.

Cisplatin – platinum-centered antitumor drug

2.

HPA-23 - antimonium tungstate, tungsten-based HIV antiviral

3.

Pepto-Bismol – bismuth subsalicylate, treats stomach discomfort

4.

Lithium carbonate – mood stabilizer for bipolar disorder90

5.

Metallo-antibiotics:
A. Streptonigrin – Cu- or Fe-bound antibiotic and antitumorogenic91
B. Tetracycline – a broad spectrum antibiotic that can bind to various transition
metals92
C. Bleomycin – antibiotic and antitumor drug that binds Fe, Zn, or Cu, discussed
in Section 4.1 of this chapter
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D. Bacitracin – a metallo-antibiotic that prevents cell wall synthesis, discussed in
detail in Chapter 3

As their name suggests, metallo-antibiotics are antibiotics that rely on a metal ion for
their structure and/or antibiotic function. The metals involved range from the first row
of transition elements on the periodic table to the third row! From the evolutionary
perspective, the incorporation of metals into peptides as a means of preservation of the
host was inevitable given the availability of metals in the environment, especially the
soil and ocean, and the potential harm caused by metals without regulation. Culturally,
the human species have been administering, metals, metallo-antibiotics and other
metal-activated medicines for several thousand years, sometimes to the point of adding
arsenic to their drinking sources!93
Compared to their non-metal counterparts, metallo-antibiotics are have been
drastically under-represented in research and in application. Despite the lack of
representative interest in metallo-antibiotics their current uses are varied and tend to be
highly effective. The modes-of-action can range from DNA intercalators that prevent
DNA replication and transcription, to cell membrane disruption, to inhibiting cell wall
synthesis. Another example of a quintessential metallo-antibiotic, bacitracin, is explored
in more depth in Chapter 3.
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4.1. Bleomycin

Bleomycin (BM, Figure 1.8) is a multifunctional drug that can act as an antibiotic
and antitumor drug that is naturally produced by Streptomyces verticillus and several
other strains of Streptomyces. The exact mechanism-of-action for bleomycin is not
currently understood completely, though, there is evidence for it binding to and
cleaving genetic material, including DNA, RNA, and tRNA.94,95 Research on the metal
presence has shown their importance in performing either single or double stranded
cleavage of DNA in the presence of Fe or Cu and DNA binding in the presence of
Zn.96,97 Bleomycin has been shown to have biological interactions against tumors as
well, due to these biomolecular interactions.98 Predominant focus has been on the ironbound form, owing to its high antineoplastic activity, although the copper form was the
originally isolated antibiotic. Complexation of the copper ion with bleomycin has been
evidenced by several methodologies. Electronic d-d transitions have been observed
~600 nm with ε600 of ~110 M—1 cm—1, indicating a likely pseudo-type 2 copper center. A
crystallographic study of the cobalt(II) complex showed metal binding at the histidine
imidazole, β-aminoalanine, pyrimidine, the β-hydroxyhistidine amide nitrogen, and the
β-aminoalanine amine as shown in Figure 1.8.102,99 The nitrogen binding motifs were
also confirmed by electron spin-echo envelope spectroscopy and EPR.100,101
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Figure 1.11 – line structure of bleomycin (bottom) and cobalt-bound structure of the
metal binding portion of BM (top), adapted from PDB ID 1JIF102

Metallo-bleomycin’s mechanism-of-action as an antibiotic is also what gives it its
versatility in treating cancer. The metallo- form of the drug can bind the minor groove
of DNA, likely with stabilization by secondary binding of DNA with the bithiazoline
rings.103 The redox-active metal-center in bleomycin can activate O2 or H2O2 to produce
superoxides or free-radicals, in a manner discussed in previous sections, which in turn
react with the deoxyribose component of DNA and, subsequently cleave DNA. A study
on the Fe-bleomycin complex by Burger, et al. found metal-mediated deoxyribose
31

cleavage of the C3’-to-C4’, and the C1’-to-ring-oxygen.104 Earlier studies on the
copper(II) complex with 1,10-phenanthroline showed similar activity, laying the
groundwork for elucidating the iron-bleomycin complex.105
Metallo-antibiotics are likely a staple of life for as nearly as long as life, as we
know it, has existed. The ubiquity of environmental metals, like copper and iron, have
made antibiotics versatile and efficacious towards a number of diseases listed in the
opening of this section. Only in the last hundred years have humans developed the
means to understand, isolate, synthesize, and prescribe antibiotics. Metallo-antibiotics
have yielded some of the long-lasting antibiotics, like bacitracin discussed in Chapter 3.
Biological systems have been using them for many, many millennia. As bacteria and
fungi are the primary sources of natural antibiotics, they can influence disease in
agricultural settings as well, affecting plant and animal life, growth, and soil
conditions.106,107

V.

Copper and Secondary Metabolite Interactions

An intersection of food, disease, drug design, and evolution is briefly described as it
relates to effects observed in the following chapters. They are often recognized as
antibiotics, defensive compounds, chromophores, or compounds that can protect
against oxidative stress; often playing multiple roles in the biological system.
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Humans have been interested in secondary metabolites indirectly for centuries. The
prominence of these compounds in research has been steadily growing over the
decades as well. They can often be the source for future drug design, such as salicylic
acid being used as to form the effective aspirin known so well today. In furthering our
understanding of human health and its relationship with diet, secondary metabolites
have gained favor among the public as well, who are often seeking means of healthy
living without the use of in vitro synthesized molecules. Unfortunately, the extent to
which secondary metabolites can be beneficial has not had the same scrutiny as the
synthetically derived molecules until more recently. Later chapters explore some of the
relationships that specific secondary metabolites, such as betanin and salicylic acid,
might have in the presence of copper.

5.1. Flavonoids (Quercetin and Myricetin)

With >10,000 unique compounds, flavonoids are a huge chemical class of secondary
metabolites produced by plants, especially fruits and vegetables. Some of the highest
concentrations in foods can be found in dried herbs like oregano and parsley (~4.5
g/kg), capers (0.49 g/kg), and some teas.108,109 They generally consist of three sixmembered rings with varying substituents based on alcohol and ketone groups, with
the exception of the chalcone class that is opened on the central 3 carbon ring. For the
sake of brevity, I will only be discussing the a few classes and examples that are
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involved in metal binding, but there are a few good reviews that go into detail on the
qualities of all the classes and subclasses.110-112

Figure 1.12 – general flavonoid structure with number assignments (left), myricetin
(middle), and quercetin (right)

Structurally, many flavonoids are “ripe” for the capacity to bind metals. On the
flavonol subclass the keto-enol moiety on carbons C3-C4 and the keto-phenol moiety at
C4-C5, along with some interaction with the catechol and polyphenol moieties, are the
most likely candidates for metal-binding. In one comprehensive study, paramagnetic
NMR using Co2+ as a paramagnetic metal binding probe, have confirmed this
interaction with quercetin and myricetin.113 Displacement of the C3-OH proton forming
the negatively charged α-ketoenolate, long catechol T1 values, and shorter C3’ and C6’
T1 values indicate enolate binding at C3-O—; wherein T1 is proportional to the distance
from the paramagnetic center to the sixth factor (T1 α rM-H6). Moreover,
spectrophotometric studies show clear electronic transitions for flavonoids ~360-380 nm
representing the A and C rings, and an absorbance band ~270 nm depending on the
conjugation and electron density of side-groups. Binding of metals, such as copper,
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calcium, and ytterbium, show an apparent red shift in electronic transitions. This
allowed for facile determination of metal binding to show 1:1 M-Qr and M-Mr in
DMSO.113
Based on the 1:1 binding of metal-flavonoid interaction, this could yield
inhibitory effects in the dysregulation of metals, allowing for ternary complex
formations with metal centers in the metallo-biomolecules and prevention of ROS
activation. This might give some insight towards versatility of flavonoids as antibiotic,
anticancer, and antioxidant compounds. Flavonoids have been shown to potentially
inhibit oxidation chemistry involved in AD by binding to CuAβ, and inhibiting cancer
growth where metals are required in higher concentrations in growth factors.113,114

VI.

Conclusion

As explored in this small introduction of metallo-biomolecules, metals have an
undeniable role in life on Earth. With origins of metal involvement in aerobic life,
metals are essential. They are even incorporated into biomolecules that reduce invasive
biotic activity, as seen with bleomycin, and ROS activity, as discussed with SOD1. Their
dysregulation, unfortunately, often has adverse effects on the host organism in diseases
like Alzheimer’s and ALS. Subsequent chapters explore some of the environmental
interfaces between metals and biomolecules. Human disease, plant metabolites, soil
bacteria, and future drugs can all have a role in binding to metal active centers like
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copper. Herein, these interactions are explored in order to better understand the role of
copper in disease, disease treatment, and the chemistry that is occurring in the
environment.

VII.
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CHAPTER 2
“Beeting” Alzheimer’s: Prevention of Cu2+-Amyloid Beta Mediated Oxidationa,1,2

It is a physical disease, not a mystic curse; therefore it will fall to a physical cure. There’s time to
kill the demon before it grows.
- Sir Terry Pratchett on his battle with Alzheimer’s disease before passing away in 2015 3

I.

Background

1.1. Alzheimer’s Disease

The molecular cause of AD via neuronal degeneration is thought to be due, in
part, to the aggregation of misfolded peptides called amyloid-β (Aβ) on neuronal

a

Presented in part at the Spring 2018 National Meeting & Expo in poster and featured

by an ACS press release in a press panel. The press release on this research has been
shared by Newsweek, Phys.org, and social media like Youtube.1,2
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tissue.4 While the broader causes of the disease through genetics and environmental
factors were discussed in the first chapter, this chapter focuses on the role of CuAβ in
the amyloidogenic pathway of the disease, especially the copper active center.
Physiologically the disease is currently thought to be based on neuronal cell
death due to inflammation. Several ideas have been put forth to explain the induction of
cell inflammation, including the presence of Tau proteins and/or accumulation of misfolded Aβ peptide. In the case of β-amyloid, inflammation is thought to occur as Aβ
accumulates on brain tissue. The aggregation is thought to be induced in a cascade of
misfolding Aβ peptides. The misfolded form of Aβ, having a relatively small size (40-42
amino acids long), can pass through the blood-brain-barrier. More recent studies have
elucidated that both the polar and non-polar regions contribute towards aggregation in
different ways. Early studies found beta-sheet and amorphous protein interaction could
lead to aggregation in non-polar regions of the peptide.5,6 While some studies posit an
inhibitory role of metals inhibiting aggregations, others show differences in the charge
of the more polar regions upon binding to metals can also drive aggregation.7
The overall development of the disease from the amyloidogenic perspective
begins with the enzyme β- and γ-secretases cleaving the tail-end of the amyloid
precursor protein (APP).8,9 The amino acid sequence for the cleaved peptide sequence is
typically 40-42 amino acids long with a sequence of
DAEFR5HDSGY10EVHHQ15KLVFF20AEDVG25SNKGA30IIGLM35VGGVV40IA42 (the
predominant metal-binding amino acids, histidine, are underlined).

56

The fate of the Aβ peptide when properly regulated is not fully understood, but
it is believed to be degraded into its amino acid components under normal conditions
by the enzymes neprilysin and insulin-degrading enzymes. Some research, though,
suggests that Aβ plays a role in protecting neuronal tissue in the hippocampus.10-12
There is currently no known method to break up the Aβ aggregates under
physiological conditions, and thus no known cure for AD, though, therapies are being
researched to ameliorate the progression of AD.13,14 By targeting the mis-folded Aβ
peptide, the potential negative consequences that would be associated with targeting
the healthy Aβ form can be avoided.

Figure 2.1 - Aqueous solution NMR structure of apo-Aβ adapted from Vivekanandan,
et al., highlighting the metal-binding sidechains, His-6, His-13, and His-14, for reference,
relaxed-eye view. PDB ID: 2LFM15
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Misfolding of the peptide can occur under oxidative conditions in the presence of
singlet oxygen and peroxides, and in the presence of unregulated metals, such as Cu2+
and Fe3+. Several studies have confirmed this interaction using a variety of methods,
such as potentiometry, Raman spectroscopy, and NMR techniques.16-18 Structurally,
metals Co2+ and Cu2+ were found to bind to His-6, His-13, and His-14 as shown in
Figures 2.1 & 2.2 from the JBC study by da Silva, et al. They were also able to conclude
this conformation with relative minimized energies of each shape adopted for the Cu2+
and Cu+ ions as the metal went through a catalytic redox cycle. The Cu2+ ion forming an
octahedron minimized to −385 kcal/mol and Cu+ a trigonal shape at −318 kcal/mol.19
Early studies in AD and its Aβ origins found that Al3+ could also play a role in the
disease as certain places with high Al3+ concentrations in drinking water also had high
incidences of AD. The correlation of Al3+ and AD, though, have come under more
scrutiny in follow-up studies based on the earlier studies’ methodologies.20
To exacerbate AD and other diseases influenced by oxidative stress, the metalbound form of Aβ has been shown to promote ROS activity. Some studies suggest this
mechanism of metal binding could be related to biological sequestration of metals in
cerebrospinal fluid (CSF), which would reduce potential effects of further ROS
production in a short-term protective measure.21 Regardless of cause or effect in AD,
metal-bound Aβ has been shown in several studies and confirmed in this study, to
perform oxidative reactions which could lead to further oxidative stress implicated in
AD, neuronal inflammation, and other ROS-related diseases.
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Figure 2.2 – a proposed structure of cobalt(II) bound to Aβ1-16. Adapted with
permission. Used with permission of Journal of Biological Chemistry, from Catechol
oxidase-like oxidation chemistry of the 1-20 and 1-16 fragments of Alzheimer’s diseaserelated β-amyloid peptide, Giordano F.Z. da Silva, Ph.D., William Tay, Ph.D., and LiJune Ming, Ph.D. 280, 17, 2005.

Focus in recent years has recognized many potential chemicals that might inhibit
metal-mediated ROS activity. By preventing the metal center from reacting with
neurotransmitters and tissues in the brain, the inflammation and subsequent neuron
apoptosis could be abated. Chelation therapies have shown some ability to reduce ROS
activity and even reduce aggregation in vitro, though, studies have largely been
unsuccessful in chelation therapies in vivo.22 The cultural popularity of dietary sources
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of antioxidants has, in part, led to many studies examining phytochemicals like
carotenoids, polyphenols, vitamins, and many others for the potential ability to
ameliorate AD-related ROS activity.23-25 The requirements for this study for a novel
inhibitor towards CuAβ were its ability to bind metal, potential stability in vivo, and can
be found in a dietary source.

1.2 Betanin

Many a shirt, pants, and counter have been ruined by beets.b When staring at the
new purple stain on your hands, shirt, or counter, you can now rest assured in the
knowledge that, at its “root”, the red color from the beet is caused by betanin, or more
formally betanidin-5-O-β-glucoside. Betanin is a phytochemical found predominantly in
beetroots (Beta vulgaris), though, it can also be sourced in smaller amounts in the Swiss
chard cultivar of beetroots and the prickly pear cactus (Opuntis ficus), and even some
fungi in an interesting occurrence of convergent evolution.26 The secondary metabolite
was “unearthed” for the first time in 1918 by Schudel, a fellow graduate student at that
time, with its first recorded isolation in his dissertation.27 It is one of several betacyanic
pigments of the betalain class of secondary metabolites. In beets, betanin is produced at
~30-300 mg per kilogram of beet.28 It is biochemically produced by spontaneous

b

Sorry Erin and Dr. Ming.
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condensation after two tyrosine amino acids are modified in the shikimate pathway
using enzymes cytochrome P450 and DOPA 4,5 dioxygenase, respectively.29

Figure 2.3 – line representation of betanin and its predominant source, beetroot. Photo
by Darrell Cole Cerrato

As synthetic food colorings have come under increased scrutiny for long-term
safety, natural products have in turn become a more popular means of coloring for
foods and drinks. Betanin is listed under E162 in the European E number coding,
denoting its red color and ability to be consumed safely. It is often found in frozen
foods given its sensitivity to heat and oxygen.56 The secondary metabolite has an
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incredibly strong color with a molar absorptivity of 65,000 M—1 cm—1 at λmax of 535 nm.
The strong absorptivity is partly why it stains so well; a little goes a long way.
Like many secondary metabolites, the benefits of their production are not part of
the necessary pathways for life. Instead, their production is likely to deal with
environmental stressors, such as ROS.30 Many people have started looking at secondary
metabolites like betanin as a source to reduce free-radical or oxidative activity given
their availability in dietary supplements. Research has, in fact, shown that betanin could
be a source of antioxidation, much like the “gold standard”, ascorbic acid (vitamin
C).31,56 One study found betanin could inhibit cytochrome c oxidation in mediated by
peroxide of linoleate-tocopherol with an IC50 of 0.4 μM, stronger than the less
conjugated betaxanthin and betanadin derivatives!32 Another extensive study found
betanin performed free radical scavenging activity, in particular, which was further
elucidated upon in earlier mouse-model studies that revealed that betanin might also
play a role in tumor suppression.33-35
Unfortunately for researchers, and fortunately for your t-shirt, betanin’s
degradation is relatively simple. It is easily photo-oxidizable and degrades under pH
values >7.0. Depending on the conditions it will degrade into one of several decarboxylated or hydrolytically cleaved products, L-DOPA and betalamic acid, to yield
one of the yellow betaxanthin derivatives.66
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Betaxanthin

Betalamic acid

Betacyanin

Figure 2.4 – derivatives and degradation products of betanin

Most people recognize betanin in their diet usually when their body cannot
process it.c This condition, known as beeturia, affects about 1 in 10 people and is
recognized by a distinct and often alarming red pigment in their urine.36 The
carboxylates on betanin make its stability reliant on more acidic conditions, pH 3.0 to

c

An older Russian gentleman was very excited to talk to me after I described my

research to a group. He reminisced with me as he described a time when he was a little
boy growing up in what was U.S.S.R. His mother frequently cooked borscht, a soup
made up of mostly beets. As he thought back on it, he was laughing as he described
how he started yelling for his mother when the color of his urine was an alarming red
color!
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7.0.37,38 The low pH stability makes it more stable in stomach acids and potentially other
more acidic environments. The high concentration of the secondary metabolite, low
renal absorption, and the inherently bright color can sometimes leave it intact and still
visible through the digestive system even in small concentrations. In humans, beeturia
has been shown to be higher in people with iron anemia, making the incidence of
beeturia rise from around 13% to 80% for those suffering from untreated anemia.39
Interestingly, betanin production also seems to be higher in plants when grown
in environments with higher than normal concentrations of several divalent metal
cations, such as Cu2+, Fe3+, and Co2+. The reason for this is still not fully-understood, but
is thought to likely be a response to increased amounts of cofactors required for betanin
production or up-regulation in response to the environmental stressors.40
Several studies have also suggested a chelating role for betanin owing to the
iminodiacetic-acid-like moiety of its structure, wherein it can act as an antioxidant by
binding to and sequestering free-metals, especially copper and iron. In one study the
stability of betanin was improved in the presence of citric acid, a strong antioxidant and
also a chelator.41 Another study looked more directly at the chelating capabilities of
betanin by examining an increase in betanin stability in the presence of the
quintessential chelator ethylenediaminetetraacetic acid (EDTA).42 Missing from these
reports, though, are direct measurements of metal-binding beyond observing secondary
effects due to metal presence and the potential effects of preventing metal-mediating
oxidation.
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II.

Results and Discussion

2.1 Antioxidation of CuAβ by Bn

In combining what was known about CuAβ and the potential metal binding
capabilities of betanin, this study examined their interactions from the activity and
structural perspective. For the purposes of examining the metal-binding capabilities of
Bn, Aβ1-16 was used for all experiments in order to maintain solubility in solution. From
the metal-binding and reactivity perspective there is not a large difference between the
short peptide and the large peptide. Moreover the shorter peptide contains more
hydrophilic amino acids, maintaining solubility throughout the experiment.19
Previous studies by da Silva, et al have shown that CuAβ oxidizes catechols in
the presence of aerobic O2 and H2O2.19 Testing catechols against CuAβ has significance
given the necessity for catecholamine neurotransmitters, such as dopamine and
serotonin, for proper brain function.19,47 Simple catechols can be used as models for
early experiments to show catechol oxidase-like activity, which could give some
indication of the potentially detrimental chemistry occurring in the brain. Catechol
oxidation was measured using 3,5 DTBC in the following experiments, a standard
chemical used in measuring catechol oxidase-like activity.43,44 Simple catechols often
require forming an adduct with 3-methyl-2-benzothiazolinone hydrazine (MBTH) to
stabilize and accurately visualize the quinone product, however the adduct band would
overlap with the intense Bn band at 500-560 nm.
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Catechol

3,5 di-tert-butylcatechol Norepinephrine

Epinephrine

Dopamine

Figure 2.5 – chemical structure of catechols including neutotransitters

Based on the da Silva, et al study on catechol oxidase-like activity, a type-3 dicopper reaction center was proposed, seen in the pathway below. The mechanism in
Figure 2.6 requires a two-electron transfer which can occur in vivo using O2 and/or
H2O2. As a type-3 copper, the di-copper center the active site forms bridged
intermediates with substrates in a μ-η2-η2 fashion. Respiration and oxygen transport
molecules make O2 present in a vast majority of the human body. Heightened
production of ROS within mitochondria due to a number of mutations or dysregulation
of the peroxide regulating protein superoxide dismutase could be a potential source for
induced oxidative stress, making peroxide an “opportunistic” ROS. In combination
with cationic metals, hydrogen peroxide can more efficiently form the highly reactive
superoxide ion, responsible for the increased reactivity.45 In either the O2 or H2O2
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pathways, an inhibitor binding to the metal in lieu of the oxygen, peroxide, or the
catechol substrates could prevent turnover of the oxidized quinone.

Figure 2.6 - Adapted reaction mechanism for catechol (adapted for DTBC) with CuAβ
proposed by da Silva, et al.19 Used with permission of Journal of Biological Chemistry,
from Catechol oxidase-like oxidation chemistry of the 1-20 and 1-16 fragments of
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Alzheimer’s disease-related β-amyloid peptide, Giordano F.Z. da Silva, Ph.D., William
Tay, Ph.D., and Li-June Ming, Ph.D. 280, 17, 2005.

An initial titration of up to 7 μM Bn to CuAβ shows an apparent decrease in
oxidation of DTBC. The rate decreasing towards zero as betanin increases indicates
reduction of DTBC turnover in the presence of Bn.
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Figure 2.7 - inhibition of 3.2 mM DTBC oxidation by 3.5 μM (CuAβ)2 as a function of Bn
in a pH 6.0 buffered solvent of 1:1 MES:MeOH

68

Experiments to determine inhibition were designed based on pre-equilibrium
kinetics observed for CuAβ.19,47 For the purposes of applying Michaelis-Menten (MM)
kinetics, the following simplified pathway can be used, which allows the standard MM
pre-equilibrium kinetics equation to be applied.

Figure 2.8 – simplified reaction pathway for CuAβ oxidation of DTBC and its
quantification using Michaelis-Menten equation (Equation 2.1) and its linearized form
(Equation 2.2)

𝑣0 =
1
𝑣0

=

𝑉𝑚𝑎𝑥 ×[𝐷𝑇𝐵𝐶]

Equation 2.1

𝐾𝑚 +[𝐷𝑇𝐵𝐶]
𝐾𝑚
𝑉𝑚𝑎𝑥

×

where 𝐾𝑚 =

1
[𝐷𝑇𝐵𝐶]

+

1

Equation 2.2

𝑉𝑚𝑎𝑥

𝑘−1 + 𝑘𝑐𝑎𝑡

Equation 2.3

𝑘1

Unfortunately, due to the high absorptivity of Bn, UV-vis kinetic measurements,
while convenient for isolation and determining its concentration, are problematic
during kinetics where even at small concentrations the light receiver can be quickly
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reach the limitations of light detection between 500 and 600 nm. In the pre-equilibrium
reaction kinetics, DTBC was measured at varying concentrations while holding CuAβ
and Bn constant. Follow-up titrations would repeat the experiment with a different
amount of Bn to determine the inhibition pattern based on the linearized plot of MM,
the Lineweaver-Burk plot (Equation 2.2).
The data collected in Figure 2.9 was fitted to the Michaelis-Menten equation
(top), Equation 2.2. To determine the type of inhibition as betanin was increased the
MM fitting was converted to a double-reciprocal, Lineweaver-Burk plot and by
evaluating the Vmax,app and Km,app derived from the MM fitting . The MM parameters
from Figure 2.7 upon being fitted with the Lineweaver-Burk equation determined the
Vmax,app and the Km,app. Constants kcat and the catalytic efficiency were determined using
this data, summarized in Table 2.1.
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Figure 2.9 - 5 μM CuAB oxidizing DTBC in the presence of Bn, in 1:1 MeOH:MES at pH
6.0 at 25 °C, Michaelis-Menten fitting (top) and Lineweaver-Burk fitting (bottom).
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Table 2.1 - MM parameters of betanin inhibition of aerobic oxidation determined by
fitting each line in Figure 2.6 to the MM hyperbolic equation. (a) based on dimeric
CuAβ concentration of 2.5 μM

0.0 μM
1.25 μM
2.50 μM
3.75 μM

Vmax
(nM/sec)
159.0 ± 9.6
85.5 ± 5.6
76.8 ± 7.7
73.6 ± 6.4

Km,app
(mM)
6.6 ± 0.8
7.5 ± 1.0
10.0 ± 1.8
13.9 ± 1.9

kcata
(sec—1)
(63.6 ± 4.8) × 10—3
(34.2 ± 2.8) × 10—3
(30.7 ± 3.9) × 10—3
(29.4 ± 3.2) × 10—3

Catalytic Efficiencya
(M—1 sec—1)
9.7 ± 0.1
4.6 ± 0.2
3.1 ± 0.2
2.1 ± 0.2

Convergence of all the fits in Figure 2.9 reveals apparent mixed-type inhibition.
Titration of DTBC in the presence of varying amounts of Bn revealed an apparent
mixed-type inhibition based on both an increase in Km,app and a decrease in Vmax,app.
Further evaluation for inhibitor constants Kic and Kiu were determined based on the
following pathway in Figure 2.10:
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Figure 2.10 – mixed inhibition pathway of Bn towards CuAβ oxidation of DTBC
featuring competitive (binary EI complex) and uncompetitive (ternary ESI complex
pathways)

The stability of the binary Bn-CuAβ complex can be described by the dissociation
constant, Kic, where constants Km and Vmax are determined by fitting the MM equation
to the data obtained under no inhibition by Bn. Kic was determined by fitting a modified
MM equation where Vmax,app/Km,app are a function of Bn, Figure 2.11.

𝑉𝑚𝑎𝑥,𝑎𝑝𝑝
𝐾𝑚,𝑎𝑝𝑝

=

𝑉𝑚𝑎𝑥 /𝐾𝑚

Equation 2.4

1+[𝐵𝑛]/𝐾𝑖𝑐
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Figure 2.11 –MM fitting for Figure 2.7 as a function of Bn for the determination of the
Kic dissociation constant of Bn–CuA binary (EI) complex

Fitting Vmax,app/Km,app as a function of Bn in Table 2.1 to Equation 2.4 reveals a
Kic constant of 1.11 ± 0.03 μM, which has some interesting implications. The incubated
concentration of CuAβ was 5 μM, indicating a sub-stoichiometric competitive inhibition
of Bn towards mononuclear CuAβ. Taking into account the previous study by da Silva,
et al that proposed a dimeric active site, this data fits well with 1:1 binding of the EI
(betanin-CuAβ or enzyme-inhibitor) complex. Under the condition that 5 μM CuAβ
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would yield 2.5 μM active sites, tight binding of Bn towards a di-copper center under
these conditions would reveal a Kic near 1.25 μM, which is close to what is observed.
Similarly, the dissociation constant for the Bn ternary complex of Bn-CuAβDTBC, Kiu, in the uncompetitive pathway can be determined by:

𝑉𝑚𝑎𝑥,𝑎𝑝𝑝 =

𝑉𝑚𝑎𝑥

Equation 2.5

1+[𝐵𝑛]/𝐾𝑖𝑢

Figure 2.12 - Plot of the data from Table 2.1 fitted to Equation 2.5 in determination of
dissociation constant, Kiu, of Bn ternary binding of Bn-CuAβ-DTBC (R2 = 0.9)
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The fitted data in Figure 2.12 reveals a relatively low dissociation constant of Kiu,
2.2 ± 0.4 μM. Unlike the clear 1:1 competitive nature revealed by the Kic, the Kiu reveals
a more ambiguous value. This could be due in part to a more substrate favored
equilibrium once catechol is bound to the active center. Alternatively, this could also be
indicative of monomeric reactivity not bound to Bn under a different, but less
predominate, reaction pathway.
Unfortunately, the nature of this type of study is not able to evaluate O2 as a
substrate, where inhibition of O2 binding would prevent oxidation by preventing
electron transfer and subsequent formation of H2O2. One of the byproducts of concern
for metallo-protein oxidation is the production of H2O2 which can increase oxidation
rates through a redox cycle with a copper ion.46,47 For example, prior to normalization of
Figure 2.13, the overall rate of DTBC oxidation rose five-fold compared to ambient O2.
Given the presence of H2O2 occurring naturally and as a by-product of O2 electron
transfer, inhibition for H2O2 turnover is essential for any inhibitor to remain effective in
preventing ROS activity in AD.
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Figure 2.13 – Oxidation of 3.2 mM DTBC as a function of H2O2 titration to 5 μM
(CuAβ)2 without inhibition in 1:1 MES:MeOH solvent buffered at pH 6.0, 25 °C, kcat of
(9.3 ± 0.7) × 10—3 sec—1

Peroxide was incubated with varying amounts of Bn at 30 mM, a close
approximation to the Km determined upon fitting Figure 2.13 to yield 34.8 ± 6.4 mM,
closely resembling Km values of previous studies.19
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Figure 2.14 – Double-reciprocal plot for DTBC titration in the presence of varying
amounts of Bn with constant 30 mM H2O2 and 10 μM CuAβ

Dissimilar to the O2 example, Bn shows more competitive character in the
presence of H2O2 from Figure 2.14, though, could also be showing some mixed type
inhibition as well. The ambiguity of the nature of inhibition is based on the proximity of
the convergence point for all the fitted lines for each concentration of Bn. Pure
competitive inhibition would converge on the y-axis, indicating similar turnover
numbers and apparent maximum rates for all catalysts without Bn bound. Instead pure
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competitive inhibition would differ in Km,app alone, revealing an equilibrium pushing
away from the ES complex and more towards the binary EI complex.

Table 2.2 - MM parameters of betanin inhibition of peroxide mediated oxidation
determined by fitting each line in Figure 2.14 to the MM hyperbolic equation. (a) based
on monomeric concentration of CuAβ

Bn (μM)
0.0 μM
1.0 μM
2.5 μM
5.0 μM

Vmax
(nM/sec)
597 ± 54
569 ± 37
502 ± 27
502 ± 28

kcata
(sec—1)

Km (mM)
1.2 ± 0.2
1.8 ± 0.2
2.1 ± 0.2
2.7 ± 0.1

(29.9 ± 2.7) × 10—3
(28.4 ± 1.9) × 10—3
(25.1 ± 1.4) × 10—3
(25.1 ± 1.4) × 10—3

Catalytic
Efficiencya
(M—1 sec—1)
24.7 ± 0.2
17.2 ± 0.1
11.4 ± 0.1
9.2 ± 0.1

In a similar analysis compared to the inhibition of CuAβ by Bn with aerobic O2,
the stability of the ES complex CuAβ-DTBC decreases as the apparent Km increases.
Investigating the competitive nature of Bn towards the metal center in the presence of
H2O2 reveals a Kic of 2.3 ± 0.3 μM, where the concentration of monomer CuAβ is 10 μM,
fitted in Figure 2.15. Similar to the O2 evaluation, the sub-stoichiometric constant likely
indicates inhibition of a dimeric catalyst, making the effective concentration of CuAβ at
5.0 μM. The Kic for DTBC in the presence of H2O2 is comparable to that of the Kic in the
presence of O2 with reference to the Km of(CuAβ)2. This relative stability of the EI
complex against DTBC binding is consistent despite the electron source for turnover, O2
versus H2O2.
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Figure 2.15 - Replot for Kic dissociation constant determination of Bn binary complex in
the presence of 30 mM hydrogen peroxide

As explored in detail in Chapter 1, excessive generation of H2O2 can further
exacerbate redox activity when unregulated. Disproportionation or catalytic turnover
into the highly redox active superoxide, O2•—. A strong inhibitor bound to the metal
active could prove to be a potent redox inhibitor. Competitive inhibition would show a
favor in equilibrium towards the EI complex, or an inhibitor as large as betanin could
alternatively prevent H2O2 access to the binding.48,32

80

Inhibition towards CuAβ with reference to H2O2 as a substrate was performed in
the presence of varying amounts of Bn, Figure 2.16. For each peroxide titration, betanin,
DTBC, and CuAβ were held constant, whereby Bn was varied in subsequent
experiments to ascertain Vmax,app and Km,app as a function of Bn. Based on the data profile
the type of inhibition was evaluated for its competitive, uncompetitive, or mixed
inhibition pattern. Given the non-zero value for rate without peroxide (𝑦0 ), the data
were fitted to a modified MM equation:

𝑣0 = 𝑦0 +

𝑉𝑚𝑎𝑥 ×[𝐻2 𝑂2 ]

Equation 2.6

𝐾𝑚 +[𝐻2 𝑂2 ]

The profile for hydrogen peroxide titration, upon fitting the data to the doublereciprocal Lineweaver-Burk plot, Equation 2.6, revealed a mixed inhibition pattern.
This is further verified by analyzing Km (competitive) and kcat (uncompetitive) shown in
Table 2.3. The increase in apparent Km values from the Km without Bn reveals
competitive inhibition via Bn binding directly to the active site. Moreover, an evaluation
of Vmax shows uncompetitive type inhibition. These pathways can be tentatively applied
to Figure 2.17, though, the uncompetitive pathway might require further evaluation to
elucidate the nature of this type of inhibition towards H2O2 binding.
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Figure 2.16 - Bn inhibition of H2O2 as a substrate for DTBC (1 mM) turnover by 5 μM
CuAβ

Table 2.3 – MM parameters of betanin inhibition of hydrogen peroxide mediated
oxidation with respect to H2O2 determined by fitting each line in Figure 2.14 to the MM
hyperbolic equation. (a) based on dimeric concentration of CuAβ

Bn (μM)
0.0 μM
0.625 μM
1.25 μM
2.50 μM

Vmax
(nM/sec)
103 ± 11
69 ± 13
50 ± 15
38 ± 3

Km (mM)
3.5 ± 0.1
4.1 ± 0.2
4.6 ± 0.3
6.0 ± 0.8

kcata
(sec—1)
(41.2 ± 4.2) × 10—3
(27.5 ± 5.2) × 10—3
(18.8 ± 6.0) × 10—3
(15.3 ± 1.2) × 10—3
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Catalytic
Efficiencya
(M—1 sec—1)
11.8 ± 0.2
6.8 ± 0.4
4.1 ± 0.6
2.6 ± 0.2

Figure 2.17 – simplified reaction pathway in describing Bn competitive and
uncompetitive inhibition pathways towards H2O2 reactivity with CuAβ.

In evaluating the competitive dissociation constant, Kic, for the the Bn-CuAβ
complex, Vmax,app/Km,app were plotted as a function of Bn. Fitting this data to Equation
2.4 revealed a Kic toward H2O2 turnover of 0.76 ± 0.04 μM. This value is curiously low,
given that 50% inhibition would occur at 1.25 μM betanin with dimeric CuAβ. This
value could be indicative of error propagation in measuring slow reactions. Chemically,
this value could also partially indicate decomposition of H2O2 through H2O2-Bn
interactions. Studies have shown several pathways by which Bn can by oxidized by
peroxidases in the presence of hydrogen peroxide. Moreover, the cited study found
some of the antioxidant electron pathways occurring in the non-metal-binding motif.49
Secondary interactions likely would not account for a Kic twice as low as expected for
most strong inhibitors and would require more exploration in the binding of Bn and
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CuAβ. Moreover, the presence of peroxide might also induce small amounts of
oxidation on the peptide that could trigger small amounts of aggregation of the peptide
not observed in previous studies, thus sequestering the active metal center.

Figure 2.18 – Replot for Kic dissociation constant determination of Bn-CuAβ binary
complex, inhibiting H2O2 binding

On top of the competitive inhibition exhibited by betanin towards hydrogen
peroxide binding, betanin also showed uncompetitive inhibition. In this pathway the
dissociation constant, Kiu, for the Bn-CuA-O22— ternary complex. Fitting the Vmax,app
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data recorded in Table 2.3 with respect to the Bn concentration yields Figure 2.19. Upon
fitting the apparent Vmax values as a function of betanin to Equation 2.5 reveals a Kiu for
the ternary complex of 1.28 ± 0.08 μM. Uncompetitive inhibition towards the ESI
(betanin-CuAβ-DTBC or enzyme-substrate-inhibitor) complex indicates a lack of
turnover upon binding of the ternary complex. This implies that Bn could play a role in
the electron transfer process, making superoxide oxidation unfavorable. A study by
Kumorkiewicz, et al on Cu2+ and Cu1+ turnover in the presence of betanin, using the
proposed binding motif explored in the subsequent section herein, have explored
mechanisms by which betanin can interact in the redox process.50 The high conjugation
of betanin makes one of several betacyanin derivatives stably possible.
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Figure 2.19 - Replot for Kiu dissociation constant determination of Bn-CuAβ-H2O2
ternary complex turnover

2.2 Betanin-Copper Binding

In understanding the inhibitory effects of Bn towards CuAβ, several experiments
were performed to examine the nature of the Cu2+ ion to Bn. Studies have examined the
degradative qualities metals have in solution towards Bn that have also been observed
in this lab when betanin and metal interact under unbuffered conditions.51 Fortunately,
relatively “fast” experiments (10-20 minute incubation periods) showed relative
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stability under buffered conditions at pH 6.0. Qualitatively, a titration of Cu2+ to Bn
reveals a decrease in the Bn signal at 535 nm and an apparent new signal forming at 505
nm, shown in Figure 2.20. Apparent Cu2+ saturation appears at ~50 μM, indicating the
equilibrium of the metal-ligand complex.

Figure 2.20 - normalized UV-vis spectrum for the titration of Cu2+ to Bn in MES pH 6.0
buffer.
Prior to determining the association constant for the Cu2+-Bn complex, the
stoichiometric relationship of the two were determined. Job plots, or methods of
continuous variation, can reveal how a physical attribute, such as light absorbance or
chemical shift, can change based on the equilibrium of a complex. As the common name
suggests, both compounds are simultaneously varied for each point to maintain a total
concentration. Copper-ligand binding can often be observed by taking advantage of d-d
transitions or charge transfer transitions that can be measured in a UV-vis spectrum.
Figure 2.21 shows a Job plot where the absolute value for the change in absorbance was
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measured at 400 nm as a function the molar ratio of copper where the Cu:Bn
concentrations were held at a total 9.1 μM throughout the experiment. The absorbance
at 400 nm was chosen to reduce the influence unbound Bn would have on the
measurement. Without fitting, the mole fraction ratio (χCu:χBn) is approximately 0.3:0.7,
suggesting that a 1:2 Cu2+:Bn complexation is a predominate species under the given
conditions.
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Figure 2.21 – Job Plot (continuous variation) for Cu-Bn absorbance due to binding as a
function of the mole fraction of Cu2+, χCu, in 100 mM pH 6.0 MES buffer
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This yields a complexation equilibrium of:

Where

and

𝐾𝑎1 =
𝐾𝑎2 =

[𝐶𝑢𝐵𝑛]
[𝐶𝑢][𝐵𝑛]

[𝐶𝑢𝐵𝑛2 ]
[𝐶𝑢𝐵𝑐][𝐵𝑛]

Equation 2.6

Which can be expanded to for binding constant terms, Ka1 and Ka2 (Equation 2.7):
0 = [𝐶𝑢]3 𝐾𝑎1 𝐾𝑎2 + [𝐶𝑢]2 {𝐾𝑎1 (2𝐾𝑎2 [𝐵𝑛]0 − 𝐾𝑎2 [𝐶𝑢]0 + 1))} + [𝐶𝑢]{𝐾𝑎1 ([𝐵𝑛]0 − [𝐶𝑢]0 ) + 1} − [𝐶𝑢]0

While 1:1 complexes can still retain a relatively more trivial analysis, it still contains a
quadratic function. In the 2:1 binding case, equilibrium constants determinations would
require solving a cubic function! Many current software have some capabilities for
fitting these complex equations with multiple parameters. The Nelder-Mead method of
fitting optimization was employed through a Matlab platform, BindFit.52,53 Fitting of
Figure 2.22 for a copper titration to Bn using BindFit software revealed Ka1 of (6.4 ± 2.5)
×104 M—1 for the first equilibrium of 1:1 and (2.2 ± 0.3) ×104 M—1 for the 2:1 Ka2
equilibrium.
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Figure 2.22 – Titration of Cu2+ to Bn at 9.1 μM, in 100 mM pH 6.0 MES buffer, where the
change in absorbance at 535 nm is measured as a function of Cu2+ titrated

Assuming the 2:1 constant is valid based on the Job plot these constant show strong
binding towards Cu2+ in aqueous environments. While this is not quite as strong as
most chelators exhibiting equilibrium constants at 109-1017 M—1, this could still be an
advantage for betanin as a dietary source of preventing metal-mediated oxidation
under environments where copper dysregulation is prevalent. Chelators with relatively
large Ka constants could pose more risk than benefits as these types of chelators can
leave people anemic, ill from dysfunctional proteins deficient of necessary metal
resources required for metalloproteins and cofactors.
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Most research has either assumed binding or examined binding by observing
secondary effects. Direct evidence of metal binding, such as NMR or crystallography,
have never been published prior to this study. The challenge of the latter technique was
personally experienced as only potentially amorphous crystals could be isolated. Based
on the structure of betanin, it can be assumed that the iminodiacetic acid portion of the
molecule is likely responsible for metal binding given the close proximity of the
electronegative carboxylates and amine nitrogen. The iminodiacetic acid moiety is also
chosen over the carboxylate adjacent to the Schiff base nitrogen given the proximity of
the repulsive positive charge the Schiff base would yield towards metals, yielding a
local neutral charge.
Paramagnetic NMR can be an incredibly useful, though often under-used tool, to
examine metal-ligand binding. Paramagnetic metals can cause isotropic shifts in the
proton NMR signal, resulting in far shifted signals compared to the diamagnetic region.
While the technique is less sensitive than diamagnetic NMR, the pulse sequences can be
optimized for the fast relaxation time protons near a paramagnetic metal center
experience. The use for models in paramagnetic NMR is also helpful. Some
paramagnetic metals, like Cu2+, can yield signals so broad and far up- or downfield
from the transmitter pulse that NMR signals cannot be well-resolved. A common metal
used in lieu of Cu2+ is Co2+, given their similar binding properties and bond distances.54
Moreover the signals for nuclei proximal to Co2+ tend to be relatively sharper and
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within a reasonable spectral window for excitation.55 Figure 2.23 reveals metal binding
of Bn to up to 1 molar equivalent of Co2+ in D2O.

Figure 2.23 – paramagnetic NMR 1H spectrum of betanin with 0.25 (C), 0.5 (B), and 1.0
(A) stoichiometric equivalents of Co2+ bound to betanin at 1.1 mM in D2O.

Using water as a reference for chemical shift and intensity in each spectrum, it is
clear that several signals appear at 101.7, 38.7, 25.0 ppm. Smaller signals at 78.6, 24.4,
and 16.3 ppm can likely be attributed to a small amount of the Bn isomer, iso-betanin, or
one of several products betanin can form when degraded. Solvent, pH and presence of
metals have shown form one of several oxidized forms of betanin, many of which
maintain a metal-binding motif, such as neobetanin, a more conjugated oxidized form
of betanin.49-51 After numerous rounds of purification, as discussed in the methods
section, the most likely contaminant would be iso-betanin, a structurally identical
molecule with the exception of a single stereocenteric carboxylate, which partially co92

elutes from RP-HPLC with betanin.56 Signals at 101.7, 38.7, and 25.0 ppm are likely the
primary betanin signals based on their strong intensity. The most likely protons being
observed are the α (CH) and β (CH2) protons adjacent to the stereocentric carboxylate
and potentially the β proton adjacent to the conjugated carboxylate.
Ideally, an EXSY pulse sequence can be employed to correlate isotropically
shifted signals to their diamagnetic counterparts by taking advantage of the fast
exchange of the binding equilibrium. The typical paramagnetic EXSY pulse sequence is
a modified NOESY using short recycle times and typical mixing times of ~1-20 ms.57,58
Based on the lack of EXSY correlations observed at varying amounts of Co2+, exchange
could not be measured with the mixing times of 1, 5, 10, or 20 ms. Instead a tentative
signal assignment and structural information was explored using the model systems
discussed below.
The initial model system used was iminodiacetic acid based on the proposed
metal-binding motif of betanin. The NMR spectra of iminodiacetic acid (Figure 2.25)
showed very simple apo- form diamagnetic and metal-bound paramagnetic spectra. In
the apo- form spectrum a single signal is apparent at 3.2 ppm, assigned to both sets of
CH2 α protons. The single signal reveals the molecular symmetry and magnetic
equivalence of all four α-CH2 protons. In the paramagnetic spectrum, the signals at 84.5
and 12.3 ppm indicate two types of interactions α-CH2 protons with the electron spinsystem from the paramagnetic Co2+ ion. Given the similar peak heights and widths for
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both paramagnetic signals and a molar equivalent of both compounds, a single 1:1
Co:IDA is likely revealed.

Figure 2.24 – iminodiacietic acid compared to the proposed metal-binding region of
betanin

This can imply electronically non-equivalent geminal and vicinal protons due to nonplanar binding of the metal with respect to the relatively planar six rings of Bn. With
only one somewhat flexible, non-conjugated CH2, the six-membered ring as well as the
tryptophan moiety maintain a mostly planar shape. Despite the general planarity of the
molecule, the non-conjugated carboxylate may force out-of-plane binding with respect
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to the rest of the molecule. Differences in geminal and vicinal protons in relation to a
metal center have been observed in previous studies, often showing a more downfield
shifted signal for the equatorial proton compared to the axially positioned proton.59,60
The large difference in chemical shifts also indicates a more distinct equatorial-axial
proton positions with respect to the Co2+-carboxylate plane.

Figure 2.25 – apo-iminodiacetic acid (top) with 1 molar equivalent (2.0 mM) of Co2+ in
D2O (bottom)
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In determining the proposed geometric positions of the geminal protons with
respect to the Co2+ center on both IDA and Bn, nitrilotriacetic acid (NTA) was mixed
with an equivalent of Co2+. The NTA model would yield tridentate binding with the
additional carboxylate. This type of binding would force all protons out of the plane,
becoming equivalent on average to one another with reference to the metal center.
Figure 2.26 shows a single broad signal as opposed to the two signals found in IDA,
confirming the magnetically equivalent geminal α-CH2 protons. The broad signal at 64
ppm indicates an averaging between both protons in a geminal position when
compared to the two signals of IDA that have a 70 ppm difference.

Figure 2.26 – 1H NMR paramagnetic spectrum of 1 mM nitrolotriacetic acid with 1
molar equivalent of Co2+ in D2O
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Based on the IDA data, the signal at 101.7 ppm in the CoBn spectrum can be
tentatively assigned to the α-proton for the stereocentric carboxylate. Moreover, it
suggests the equatorial geometry of the α-CH2 proton with respect to the metal center
and out-of-plane binding of Co2+ with respect to the six-membered ring. This is
represented by an approximation of the structure in the Figure 2.27.

Figure 2.27 – a tentative structure of Cu2+-betanin (glucose not included for
minimization simplicity) minimized using Chem3D.61 Relaxed-eye view

A final study on the inhibitory effects of Bn towards free copper showed similar
inhibitory effects as the CuAβ studies. In this experiment, though, incomplete inhibition
is observed (Figure 2.28). The two methods by which this type of seemingly non-
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competitive inhibition would occur would be through binding the substrate, which is
unlikely given previous experiments, or by incomplete competition with the substrate
towards the metal binding site. As observed in the Job plot, Bn could bind at most in a
2:1 Bn:Co fashion, which could leave d-orbitals exposed for quaternary binding of
substrates O2, H2O2, and catechol. Apparent inhibition in the presence of free Cu2+ show
apparent differences when compared to the Job plot, where Bn contribution towards
inhibition appears to plateau after a single equivalent. This could be due in part to the
competition of the substrate at 4000 times the concentration of Cu2+. Moreover, this
study required organic solvent to maintain solubility of the quinone product, which
was not necessary in the binding study.
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Figure 2.28 – Inhibition of free Cu2+ oxidation by Bn (1 μM Cu, 4 mM DTBC) in 1:1 100
mM pH 6.0 MES:MeOH solvents

2.3 Beet Extract Redox Inhibition and Metal Binding

In the above studies I have measured the effects of betanin alone to determine the type
of chemistry it can employ towards copper-mediated oxidative stress. In the dietary sense
betanin will never be isolated during consumption. For those interested in seeking to apply
more beets in their diet to potentially take advantage of its anti-ROS effects, betanin, is
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fortunately among the more concentrated chemicals in beets in addition to other ROS-inhibiting
polyphenols and vitamins in beets.
The following studies are more qualitative in nature just show how beet extract is either
inhibiting catechol oxidase-like activity or a cursory view of the metal-binding capabilities of
products in the extract. A full quantitative analysis of all the products individually in beets
would be far beyond the scope of this dissertation, given the numerous beneficial compounds
currently known to be in beets would take years to catalogue and quantify.
In the first experiment I measured the inhibition of Cu2+ redox activity towards DTBC in
the presence of beet extract. The beet extract used in this experiment was obtained from beets
bought at a local grocery store. The extract was acquired after homogenization and simple
filtration through a general, large pore filter to remove cellulose and large debris from the
extract. Betanin was used as a reference for relative concentrations given its facile determination
using its strong absorptivity in the UV-vis spectrum and due to its high concentration in
relation to most other phytochemicals, especially antioxidants. Encouragingly, beet extract
shows a rapid decrease in oxidative activity towards catechols in the presence of free Cu2+,
reaching an equilibrium at ~10 μM Bn reference. The inhibition of Cu2+-mediated oxidative
activity was potentially reduced by ~50% compared to the oxidation rate measured without any
beet extract. This value might not be entirely representative of oxidation of catechol. Many
polyphenols and several derivatives of betanin can turn yellow when exposed to metal ions,
due to redox activity of the respective molecule, consistent with previous research on the effects
of Cu2+ towards Bn in an extract.62 At this stage of the purification, polyphenols, ascorbic acid,
and hundreds of other compounds still exist in the reaction vial. This could also indicate an
equilibrium reached with catechol oxidizing enzymes present, such as catechol oxidase. In this
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qualitative study, this at least shows the apparent ability for chemicals in beets to potentially
bind to metal and show how beets as a whole might have a “nutraceutical” effect towards ROS
activity.
This cursory examination of the overall antioxidant activity of beet extract could also be
misleading in the favor of more antioxidation. Observing catechol oxidation is based on
examination of a yellow color forming as the quinone is produced. Betanin has been shown to
be more stable upon isolation, where in extract form it is more apt to decompose into one of
several yellow derivatives.66 The halt in production of yellow color might reveal an equilibrium
of chemical decomposition as well as oxidation of catechol. Therefore any reduction in ROS
activity is occurring proportionally with product degradation with respect to molar
absorptivities of all compounds.
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Figure 2.29 – inhibition of free Cu2+ oxidation by beet extract as a function of Bn
concentration

In a final examination, qualitative metal binding of beet extract towards Co2+ was
observed with 260 μM Bn (71.8 μg/500 uL) as reference for the extract. Figure 2.30
shows a several strong signals. While signals at ~100 ppm and 25 ppm show potential
betanin signals, several signals show across a 200 ppm window that were not observed
Figure 2.23. Using peak heights and widths as a reference for each compound, it can be
surmised that a few predominant compounds exist in solution that have metal binding
capabilities!
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Figure 2.30 – 260 μM Bn in D2O as part of beet extract in the presence of 1 molar
equivalent of Co2+

III.

Concluding Remarks

From the perspective of betanin as a food source and not a medicine, the small
Kic and Kiu values for inhibiting CuAβ under aerobic O2 and H2O2 conditions are
encouraging. This study shows that Bn can inhibit catechol oxidase-like activity in vitro
caused by CuAβ. As more is understood about the contribution of CuAβ towards AD,
Bn provide a means of reducing the oxidative stress involved with the disease and
potentially other metal-based neurological disorders. The mixed inhibition for Bn
implies its versatility as an inhibitor towards Cu2+-mediated oxidative activity towards
catechols. Active site competition between Bn and substrates expectedly shows tight
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binding with low dissociation constants, making substrate binding difficult, especially
for catechols. Interestingly, the low Kiu values could be showing the antioxidant
versatility proposed by other previous studies.50,49 The highly conjugated structure of
Bn allows for a number of pathways that could all contribute towards the antioxidation
by stabilizing electron transfer into its complex.
This is also the first study to acquire primary data that could propose structural
information on Bn-Cu2+ binding. As previously mentioned, other studies have implied
binding by examining the degradation of Bn. This is the first study to acquire data that
shows metal binding to Bn itself. Unfortunately, the challenge of performing 2D
experiments on paramagnetic molecules due to either lack of exchange or
undetermined sequence optimization prevented the complete signal assignment,
though, it does at least conclude metal binding.
As encouraging as these studies are in potentially using betanin or molecules
inspired by betanin, there is still more to be observed. Part of the challenge in working
with betanin is that it is often not soluble or stable in many solvents making more indepth experiments, such as a binary or ternary EXSY, incredibly challenging for a
complete signal assignment!
Outside of my lab’s expertise there is still more work to evaluate in betanin’s
bioavailability. It is essential that betanin is able to pass through a number of
membranes between intestinal linings to the blood-brain-barrier to affect Aβ.63,65 Many
of the studies at the time of writing this leave room for improvement. Many secondary
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metabolites and flavonoids are not well-absorbed, though, the absorbance has been
shown to increase upon the addition of glucosides, similar to betanin. A similar metalbinding antioxidant, quercetin, was shown to have nearly 20 times the bioavailability at
10 times the gut absorption rate when bound to glucoside!64,65
This study could also be expanded upon, especially in the understanding of how
the other molecules in the betalaine family can bind to metal. Betanin often degrades by
decarboxylation or cleavage of the cyclo-DOPA moiety via cleavage of the aldimine
bond that would form one of several yellow betaxanthin derivatives. Many of these
could also have antioxidant properties given the often partially or wholly preserved
iminodiacetic acid metal-binding motif.66,67 This could make a case for investigating
betanin further against CuAβ redox chemistry since its degradation might not be the
end of the story!
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IV.

Materials and Methods

4.1 Natural Product Treatment

All beet extract was removed directly from beetroot, Beta vulgaris, purchased in a
local supermarket in Land O Lakes, Florida.d Extract was procured by peeling and
grating the root, followed by homogenization in a food processor. The collected
samples were then frozen at –5 °C overnight to further lyse cells. Cellular debris was
removed by centrifugation at 3500 rpm for 10 min. The lysate was then purified by 0.2
μm pore-sized Whatman® filters to remove any remaining cellular debris and then by
Sephadex G-25 column filtration to isolate betanin from the extract. Quality and
quantification of betanin was determined using UV-Vis spectrophotometer (ε535 = 65,000
M—1 cm—1). Further quality was measured by NMR spectroscopy (Varian Direct Drive
500 MHz spectrometer) and processed by VNMRJ.

d

Betanin can be purchased by some companies. Frustratingly, some of the companies

use techniques for “purification” do nothing to remove sugar from the compound
yielding about 1000:1 w/w sugar NMR to betanin! The 5g bottle I received turned out
to be about 4.995 g sugar. Thus, began the journey of learning natural product
extraction.
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Figure 2.31 - general purification of Bn through homogenization, micropore filtration,
and column chromatographies

4.2 Antioxidation Kinetics

Reaction rates for oxidation and peroxidation were performed using 5 uM for
ambient O2 studies and 10 uM Cu(II)Aβ for H2O2 studies titrating 0.25-12.8 mM 3,5-ditert-butylcatechol (DTBC), in 1:1 (v/v) MES:MeOH. 30 mM H2O2 were used for
peroxidative studies. The pH at 6.0 was held constant by 100 mM MES at 6.0 to
maintain Bn stability. Varian Cary 50 spectrophotometer was used to measure reaction
rate of DTBC forming oxidized o-quinone product at A410 (1900 M–1 cm–1). β-amyloid
peptide 16-mer concentration was determined at A280, where ε280 was 1490 M—1 cm—1.

107

4.3 Paramagnetic NMR

1 mM betanin was dissolved in D2O or H2O with up to a stoichiometric
equivalent of CoCl2. Paramagnetic isotropic chemical shifts for 1H nuclei were detected
using the super-weft pulse sequence (180-τ-90) consisting of 10,000 scans with a recycle
time of 100 ms. Chemical shifts were recorded using Agilent’s Varian Inova 600 MHz
spectrometer and processed with VNMRJ software. Paramagnetic 1H spectra were
processed with up to 20 Hz line broadening window function.
V.
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CHAPTER 3

Inhibition of Copper(II)-Bacitracin Mediated Oxidation By Salicylic Acid and
Thiabendazole

We know more about the movement of celestial bodies than about the soil underfoot.
- Leonardo da Vinci

I.

Background

1.1 Bacitracin

Bacitracin (Bc) is a topical antibiotic that was first discovered in 1945 by Johnson,
et al of Columbia University1. Its discovery by this group was precipitated from a
bacterial isolation from seven year old Margaret Treacy in Manhattan, New York.
Bacitracin was originally derived from Bacillus licheniformis and is now commercially
developed from the Tracy I strain of Bacillus subtilus.2,3 It was named from a
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portmanteau of its Bacillus bacterial source (bacitracin) and after a misspelling of
Treacy’s last name (bacitracin).

Figure 3.1 – relaxed-eye stereoscopic view of apo-bacitracin A1 minimized using
ChemDraw3D software4

Bacitracin has been found to be particularly useful as a narrow spectrum antibiotic for
several strains of Staphylococcus and Streptococcus, and other Gram-positive bacteria. It is
primarily used as a topical antibiotic, found in Neosporin® and Polysporin® among
others.5 It is also commonly found in livestock feed for prevention of Gram-positive
bacterial infections and subsequent growth promoter. Given its poor gastrointestinal
absorption, it is generally safe for oral use; however, it is nephrotoxic in large quantities
or if delivered in other non-oral methods.5 In Europe it maintains a “prudence” category
for livestock infection therapy by the European Medicines Agency, though, it is banned
a growth promoter.6,7 Despite the scale to which Bc is distributed, resistance is still
relatively low, most likely owing to its structure and unique mechanism-of-action.6
The general amino acid sequence for Bc was proposed over the course of a few
studies in the 1940s and 1950s. Separations techniques eventually resolved several
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congeners of the cyclic antibiotic, subsequently labeled A1, A2, B1, B2, B3, D1, D2, D3, and
F.8-10 Revisiting these studies with more modern equipment revealed upwards of 50
potential congeners.11 Structural determination has also revealed the amino acid
sequences and the variation among the congeners, summarized in Figures 3.2 and 3.3.12
The most biologically active forms have been found to be the A1 and B1 congeners that
differ by a –CH3 on the N-terminal amino acid side chain, while F is the most
biologically inactive form with a thiazole (oxidized thiazoline) at the second residue.

Figure 3.2 - Amino acid sequence for bacitracin with congener variations for R, X, and Y
amino acids represented in Figure 3.3
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Congener

X5

Y8

R

A1

L-Ile

L-Ile

R1

A2

L-Ile

L-Ile

R2

B1

L-Ile

L-Ile

R3

B2

L-Val

L-Ile

R1

B3

L-Ile

L-Val

R1

D1

L-Val

L-Ile

R3

D2

L-Ile

L-Val

R3

D3

L-Val

L-Val

R1

F

L-Ile

L-Ile

R4

Figure 3.3 – Side chain variants for R, X, and Y amino acids for the most common
bacitracin congeners
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Figure 3.4 – Line representation for bacitracin A1 congener

Determining the mechanism-of-action for bacitracin was initially difficult for
researchers and was not fully understood for nearly two decades after its discovery.
Smith and Weinberg of Indiana University eventually determined that the zinc(II)bound form of bacitracin inhibited bacterial growth ~10 times more than the apo- form
of the antibiotic. They even hypothesized that some initial studies may have observed
antibiotic activity by bacitracin scavenging metals from the glassware or media.13
Currently the most common commercial form of bacitracin is the zinc(II)-bound form.
The Bc-metal binding affinity has been established where
Cu2+>Ni2+>Co2+~Zn2+>Mn2+.14
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The discovery of bacitracin’s metal-binding capability also eventually led to
ascertaining the mechanism-of-action that could not be determined in early research
using the apo- form. A 1971 study proposed inhibition of bacterial growth via the
divalent metal in bacitracin binding to C55-isoprenyl pyrophosphate.15 The C55-isoprenyl
pyrophosphate is responsible for the transport of disaccharide lipids across the cell
membrane. Upon incorporation into the peptidoglycan layer, the disaccharide is
released upon dephosphorylation of the lipid carrier into its monophosphate form by a
membrane pyrophosphatase.16 By bacitracin binding to the pyrophosphate,
dephosphorylation by pyrophosphatase is inhibited. Thus, the disaccharide turnover is
inevitably prevented and the cell wall synthesis is compromised.17 Later studies
confirmed the role of the divalent metal of metallo-Bc and pyrophosphate complexation
via transmission electron microscopy and NMR.18,19
Among the earliest studies, His-10 and the Cys-2 thiazoline ring were proposed
to be the main sources of metal-binding by Bc.20 This was later confirmed by studies in
the 1990s using NMR to reveal the tail region of bacitracin bent towards the ring.21,22
While there was some early debate on the metal binding role of Asp-11 and the Ile-1
amino group, later studies concluded they were not involved in direct binding to
metals.23, It was eventually concluded and confirmed the following residues were
involved in metal-binding via EPR and NMR: the Cys-2 thiazoline nitrogen, the Glu-4
γ-carboxylate and the Nε of His-10.24,25 In conjunction with diamagnetic signal
assignments, paramagnetically shifted signals in the presence of Co2+ were correlated to
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their diamagnetic counterparts using EXSY techniques, resolving a more complete
picture of the metal-bound structure.25

Figure 3.5 – Calculated structure of cobalt-bound bacitracin by NMR, relaxed-eye view,
modeled based on NMR T1 data. Image used with permission by Elsevier.12

Studies in the last few decades have also focused on the versatile activity that
metallo-bacitracin can perform. Part of the reason metals tend to be avoided in drug
development processes is the lack of specificity that metals can have towards chemicals
other than the drug target. Conversely, its versatility by binding to several targets might
also hold the key towards bacitracin’s longevity. A few metal-bound forms of bacitracin
have shown activity beyond cell wall synthesis inhibition. Cu2+-bacitracin has shown
very strong reactivity towards bacterial DNA, performing both single and doublestranded DNA cleavage along the phosphate backbone.19 In fact, the Zn2+-bound form
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showed some of the least amount of DNA cleavage compared to more redox active
metals like Cu2+.
Additionally, the metallo-Bc has also exhibited potential redox bioactivity in
performing catechol oxidase-like reactions. A study by Tay, et al. found the turnover of
catechol to o-quinone of 7.0 × 10—3 s—1 and 0.38 s—1 in the presence of aerobic O2 and 32
mM H2O2, respectively.19 Medicinally some contact could occur with catechols and
polyphenols as active ingredients in topical skin moisturizers.26 Interaction between the
two could render the antibiotic and antioxidant activity for both, respectively, moot
from outside influences. From the perspective of some of the inhibitors explored in this
dissertation, catechol oxidase-like activity is of particular importance in nature and
soils. Catechol-containing compounds and polyphenols are often produced by many
plants and are often many of the chemical components in vegetables and fruits. As the
natural source of bacitracin is derived from soil dwelling bacteria, the incidences of
bacitracin and catechol moieties would occur most naturally in the presence of or by
inhabiting plants. In fact, the presence of Bacillus subtilis can be used as a barometer for
the health of the soil for plant growth.27 B. subtilis has been shown to promote root and
leaf biomass, solubilize phosphates, and stimulate growth hormone production in a
variety of plants!28,29 Additionally, measuring the redox activity against catechol
moieties allows for facile, replicable, and comparable measurements of its turnover.
The premise of this study was to examine the effects of two environmentally
available compounds that could interact with CuBc and potentially inhibit its redox
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activity. Two products were chosen for their structural simplicity, longevity of use, and
for their potential to bind metals. The two molecules studied to potentially interact with
CuBc were salicylic acid, a common secondary metabolite produced by many plants,
particularly willow trees, and thiabendzole, a synthetic small molecule anti-helminthic
drug frequently used in agriculture. By characterizing the redox activity of bacitracin in
the presence of these metal-binding compounds, will give a sense of the chemistry
occurring in the soil and during topical medicinal uses.

1.2 Salicylic Acid

Salicylic acid (SA), or 2-hydrobenzoic acid, is among the oldest and well-known
medicines in the world. Produced by and named after the Salix alba, white willow tree,
salicylic acid has been used medicinally from its tree bark source as far back as 1500
B.C. in Egypt. Reports have shown that willow bark was espoused even by Hippocrates
for its pain killer properties!30,31 Its popularity is predominantly as a precursor to the
painkiller aspirin (acetylsalicylic acid). The acetylated product was trademarked by
Bayer® in 1899, ~50 years after its initial synthesis by Frederic Gerhardt who developed
a method to simply acetylate the hydroxyl group of the phenol ring.
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Figure 3.6 – Aspirin bottle ca. 1899. Creative Commons 3.0 Image License

The sources of salicylic acid are actually varied among many different plants,
including the rice, tobacco (Nicotiana tabacum), and even potatoes (Solanum tubersum) in
small quantities.32,33 The ubiquity of the natural production has shown its importance
for the plants where it has a variety of roles including antibiotic, a growth hormone, and
an oxidative stress-reliever.34 A more recent study found that SA might play a role in
antibiotic activity against E. coli. by decreasing extracellular biofilms by ~3-fold.35
Despite more than 3000 years of medicinal use and many millennia of natural
production, the variety of roles SA can perform are still being elucidated.

Figure 3.7 – line representation of salicylic acid
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The medicinal properties of salicylic acid are generally as an anti-inflammatory
and pain reliever; it has also shown some efficacy as an antibiotic as well.36 The
mechanism of anti-inflammation is derived from its interaction with cyclooxygenase-2
(COX-2). The COX-1 and COX-2 enzymes are responsible for producing inflammationinducing prostaglandin hormones.37 Unlike the serine acetylation performed by aspirin
on the COX-1 enzyme, SA shows no interaction with COX-1 enzymes in vitro.38 One
study proposes that SA may inhibit expression of the COX-2 among other enzymes
involved in inflammation responses. A study by Mitchell, et al found that salicylic acid
can bind to the transcription factor responsible for several genes involved in prompting
inflammation. As the genes, proteins, and protaglindin hormones are down-regulated,
continued inflammation is not triggered.39 COX-2 has also been implicated in some
cancers where it can play a role in triggering a number of tumorigenic responses, such
as angiogenesis. Thus, the down-regulation of these enzymes for diseases like colon
cancer by salicylic acid reduce tumor growth.40
The interaction of salicylic acid with metals has long been established. A 1958
study was initially able to show the metal binding capability of SA, which, however,
did not quantify the binding capacity of the complexes in aqueous environments.
Qualitatively, the SA-metal complexes followed the Irving-Williams series of metalligand stability, where Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+.41 Potentiometric studies
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eventually confirmed the earlier study and elucidating stability and thermodynamic
constants associated with salicylic acid chelates towards several divalent metals.42
In conjunction with SA’s general antioxidant activity, it has also shown efficacy
towards antioxidation mediated by redox active metals.43,44 The studies in the first part
of this chapter explores the relationship between CuBc and SA in terms of redox
functionality and structure.

1.3 Thiabendazole

Unlike salicylic acid and bacitracin, thiabendazole (Tbz) is a synthetic compound.
Tbz, or 2-(4’-thiazolyl)benzimidazole, was originally developed in the 1960s and was
patented by Merck® in 1969.45 It is mainly used as an antihelminthic and antibiotic on
food products. Its uses today are still much the same and is sold commercially under a
variety of names, such as Arbotect, and Mintezol.

Figure 3.8 – line representation of thiabendazole
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Thiabendazole is generally regarded to be an inhibitor towards fumarate
reductase, an enzyme involved in electron transport in the eventual production of
ATP.46 Other studies have shown the mechanism-of-action might vary or play multiple
roles in its antibiotic activity, including the inhibition of non-polymeric tubulin
synthesis, ubiquinone, or even activation of myeloperoxidase to cause toxicity in
mice.47-49
U.S. Environmental Protection Agency regulates Tbz as a crop antibiotic, where
they allow it to be applied to most food crops. Additionally, it has found use as an
antibiotic for paints and carpets to prevent molding. Moreover, it is also used in the
treatment post-harvest as a preservative, especially apples, bananas, and citrus.50
Current EPA crop tolerances vary by food. EPA ranging from as high as 30-40 ppm or
more for foods with waxy peels, while most allow for ~1 ppb. Environmental exposure
naturally varies since its presence depends on those that apply it, local weather, and
crop drainage. Though it was banned in the European Union as a crop preservative for
a number of years, legislation in 2015 reinstated it as an accepted for commercial
agriculture use.51
As previously discussed with betanin, synthetic chemicals in food have come
under more scrutiny from the public regarding public health. The oral LD50 of Tbz for
rats is ~3.5 g/kg, which is a relatively high dose for most drugs to induce death.
Conversely, fish seem to be far more sensitive towards the antihelminthic.50 More
concern and research has currently examined low dose exposure for potential
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cumulative toxic effects. While it is classified as potentially carcinogenic, early research
in the 1970s up to more recent studies have shown Tbz to be antitumorogenic when
application is more controlled in terms of application locale and concentration.52,53
Despite higher than normal concentration of Cu2+ under tumorigenic conditions, Tbz
showed little antitumorogenic activity. Conversely, the study showed Tbz exhibited
more chemotherapeutic activity when coordinated to copper prior to incubation.54
The capacity for Tbz to bind to metals has been known for nearly as long as the
chemical has been in use as an antibiotic. Tbz:metal complexes of 1:1 and 2:1 were
originally observed for Cu2+, Zn2+, Co2+, and Ni2+, and was eventually expanded to
include even heavy metals like mercury.55,56
While many research aspects on Tbz have examined its antibiotic properties,
antitumoregenesis, metal-binding capabilities, or bioremediation, this study herein
sought to examine the chemistry that might be occurring in the soil. As some of the
bacteria that produce bacitracin are essential for soil health, the interactions between
Tbz and metallobacitracin could yield some indication about how Tbz can affect the
crop environment other than its intent as a preservative. CuBc is chosen as a prototype
in this study owing to easy monitoring of its metal-mediated redox activity that can
faithfully reflect its interactions with the phytochemical salicylic acid and synthetic Tbz.
The study is expected to provide further insights into the multiple equilibria microbrial
metallomolecule (metallo-Bc), a metal-binding phytochemical (salicylic acid), and a
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metal-binding synthetic compound Tbz, which would also “dig up more dirt” on the
microecological balance within the soil at the molecular levels.

II.

Results and Discussions

2. Salicylic acid as an inhibitor against Cu-bacitracin

2.1.1

Aerobic Oxidation

Previously, Cu2+-Bc (CuBc) was studies for its ability to bind pyrophosphate, cleave
the phosphate backbone of DNA, and oxidative activity towards catechols.Error! Bookmark
not defined.

The metal center in all these cases played an essential role for the various

activities. The previously observed catechol oxidase-like activity was a means to
measure oxidative activity. In this study the catechol-containing substrate can also
emphasize the role catechol-containing compounds CuBc might encounter in medicinal
or agricultural roles. The mechanism of catechol oxidation by CuBc was determined in
the aforementioned study by Tay, et al.19 It was proposed to follow a mechanism based
on mono-copper center.19 To oxidize catechol into quinone, a two electron transfer
process is required. The oxidation of the substrates was investigated under aerobic O2
and H2O2 conditions. The generation of peroxide under reductive conditions have been
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extensively presented in literature which is also an essential mechanism to explore as it
has shown strong reactivity in creating oxidative stress.

Figure 3.9 – Proposed catechol oxidation mechanism for CuBc. Adapted with
permission from “1H NMR, Mechanism, and Mononuclear Oxidative Activity of the
Antibiotic Metallopeptide Bacitracin: The Role of d-Glu-4, Interaction with
Pyrophosphate Moiety, DNA Binding and Cleavage, and Bioactivity. Copyright 2019.
American Chemical Society. A proposed mechanism for aerobic and hydrogen peroxide
assisted oxidation of o-catechol to form o-quinone”.19

In the following studies DTBC was used as a substrate towards oxidation, similar to
the previous studies. Herein DTBC acted as a model substrate for the investigation of
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the oxidation of neurotransmitters discussed in Chapter 2 since DTBC can be
representative of the numerous catechols found in nature. In the soil, catechols are often
distributed by plants and bacteria. Testing against a model catechol like DTBC allows
for comparison of oxidative activities occurring in the soil. The following are but a few
catechols produced by most plants:

Catechin

Gallate

4-ethylcatechol

Quercetin

Figure 3.10 – common polyphenol and catechol-containing secondary metabolites
produced by plants

Catechol-containing compounds are ubiquitous among plant-life. They are
considered secondary metabolites given that they do not play a direct role in the
metabolic activities required for the plant to live. They have shown the ability to
reduced ROS activity, thus preventing genetic or metabolic damage, as well as some
antibiotic activity.57,58 Potential antibiotic interactions are not limited to plant life either.
Several flavonoid catechols can also be found in skin-care products for their protection
UV-B light radiation and potential carcinogens.59,60
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Oxidation of DTBC by CuBc under aerobic conditions revealed a similar
substrate kinetic pattern to studies published by Tay, et al, showing a saturation in
activity of the substrate catechol in Figure 3.10.19 This type of reaction kinetics can be
described in the aforementioned Michaelis-Menten pre-equilibrium kinetics using the
reaction pathway shown in detail in Figure 3.9, and simplified in Figure 3.12.
DTBC Oxidation
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Figure 3.11 – Oxidation of various concentrations of DTBC by 10 μM CuBc (1:1) under
aerobic conditions in 1:1 MeOH:HEPES (pH 7.0, 100 mM) at 25.0 °C
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Figure 3.12 – simplified aerobic catechol oxidase-like pathway for CuBc oxidation of
catechol to quinone by CuBc

A concerted effort was made to ensure comparability with previous studies,
though, the SA-CuBc complex and DTBC required a mixed solvent to maintain
solubility. The kinetic parameters, determined by fitting the data in Figure 3.11 to the
Michaelis-Menten, Equation 2.1, revealed a Km of 1.79 ± 0.3 mM and kcat of (1.74 ± 0.09)
× 10—3 sec—1, comparable to previous studies. Slight variations could occur due to
general solvent environment, which could strengthen or weaken the binding of the ES
complex (CuBc-DTBC), or change the diffusion of the substrate or products.
Initial titrations of salicylate took relatively large quantities of SA to perform
significant inhibition towards constant amounts of CuBc and DTBC, shown in Figure
3.13. At 10 μM CuBc this shows relatively weak inhibition given oxidation is still
occurring after 64 equivalents of SA were added.
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Figure 3.13 – titration of SA to 10 μM CuBc in 1:1 MeOH:HEPES (pH 7.0, 100 mM), 2
mM DTBC

The inhibition pattern for salicylic acid was determined by titrating DTBC in the
presence of 100 μM CuBc and a fixed concentration of SA. Subsequent experiments
varied the amount of SA to determine what manner SA inhibits DTBC turnover. CuBc
was increased in these experiments given how slow some of the inhibited reactions
could occur at high concentrations of SA and low concentrations of DTBC. Using 100
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μM CuBc allowed for facile determination of absorbance change without increasing
measurement error by approaching instrumentation limits.

0.08
10.0 mM SA
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Figure 3.14 – Lineweaver-Burk plot for varying concentrations of salicylate as an
inhibitor against oxidation of various concentrations of DTBC by 100 μM CuBc in 100
mM pH 7.0 1:1 HEPES:MeOH
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Table 3.1 – MM parameters determined from fitting Figure 3.14 as a function of [DTBC]
by 100 μM CuBc with different amounts of SA

SA (mM)
0.0
2.5
5.0
10.0

Vmax
(nM/sec)
475.7 ± 28.5
447.3 ± 14.2
405.7 ± 27.1
301.1 ± 15.2

Km (mM)
9.3 ± 1.2
12.9 ± 0.8
15.6 ± 1.9
17.1 ± 1.6

kcat
(sec—1)
(4.76 ± 0.29) × 10—4
(4.47 ± 0.14) × 10—4
(4.06 ± 0.27) × 10—4
(3.01 ± 0.15) × 10—4

Catalytic Efficiency
(M—1 sec—1)
(5.11 ± 0.73) × 10—2
(3.48 ± 0.24) × 10—2
(2.60 ± 0.36) × 10—2
(1.76 ± 0.19) × 10—2

The inhibition pattern shown in Figure 3.14 shows apparent mixed inhibition
with competitive and uncompetitive inhibition. The parameters for fitting the
Lineweaver-Burk plot were determined using Equations 2.1 and 2.2 (Chapter 2). The
data shown in Table 3.1 supports this fit as apparent Km increases and apparent
turnover (kcat) decreases. An increase in Km would indicate formation of the binary
CuBc-SA (EI) complex, yielding the term Kic, the dissociation constant for the EI
complex. Alternatively, the uncompetitive pathway would indicate competition
towards the ES complex, forming the ESI complex and preventing turnover, yielding
the Kiu term as the dissociation for ESI complex.
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Figure 3.15 – competitive and uncompetitive SA inhibition pathways of DTBC
oxidation by CuBc

The competitive inhibition constant, Kic, was determined using Equation 2.4,
where the inhibitor concentration was replaced by the concentration of salicylic acid.
The ratio of apparent Vmax and Km as a function of SA was plotted in Figure 3.16. The
competitive inhibition constant for SA-CuBc was found to be 5.24 ± 0.03 mM. As
previously observed in Figure 3.14, the inhibition of SA against CuBc is a relatively
large value, 50 times higher than the concentration of CuBc. Under these conditions it is
likely that SA is binding via its deprotonated carboxylate, which is comparable to
catechol Michaelis constant, Km, of 9.3 mM. Given its high dissociation constant, SA
would not likely be considered as a drug towards preventing oxidation of catechols
moieties. SA could provide an alternative binding pathway against CuBc in soils
especially in highly concentrated regions adjacent to plant materials. This could also be
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indicative of the mutually beneficial relationship B. subtilis has with plants, where
inhibition of CuBc or other metallo-Bc compounds would be counterproductive.

Figure 3.16 - Fitting of apparent Vmax and Km as a function of SA concentration to
determine Kic of SA, fitted to Equation 2.4.

The uncompetitive pathway was explored by plotting Vmax,app as a function of the
inhibitor concentration, Figure 3.17 This figure describes the uncompetitive binding of
the ternary (ESI) complex between SA-CuBc-DTBC. The Kiu for this pathway was
determined by fitting the data to Equation 2.5, where SA was substituted as the
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inhibitor of interest. The poor fitting for this data likely indicates that the uncompetitive
pathway is still within the linear region of fitting at the concentrations used for SA,
especially given the Kiu of 21 ± 3 mM. This value is more than double the highest SA
concentrations, indicating the SA concentrations used to investigate are relatively too
low for the fit of this pathway. This value also indicates a relatively unstable ternary
complex in favor of the CuBc-DTBC complex. Based on the more favorable equilibrium
for the competitive pathway. This data could imply the space required for ternary
binding is simply not favorable between the Bc ligands and DTBC. Solvent polarity
might also play a role where the binding pocket might alter active site exposure based
on hydrophobic/hydrophilic interactions.

144

Figure 3.17 – Fitting of apparent Vmax as a function of SA as fitted by Equation 2.5
(R2=0.92)

2.1.2

Oxidation in the Presence of H2O2

As part of the pathway shown in Figure 3.9 hydrogen peroxide can turnover the
copper center in an alternative pathway. In aerobic biological systems and in the
environment, peroxide can be present due to reaction byproducts and can be found in
quantities of up to ~40 μM in rainwater.61,62 Addition of H2O2 to CuBc exhibited strong
reactivity towards DTBC. At 10 μM CuBc and constant 1 mM DTBC, H2O2 titration
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revealed showed a 50 ± 6 mM Km,app, 0.48 ± 0.02 sec—1 H2O2 turnover, and an efficiency
of 9.71 ± 0.13 M—1 sec—1.
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Figure 3.18 – titration of hydrogen peroxide to 10 μM CuBc and constant 1 mM DTBC,
normalized for fitting to determine Km,app

CuBc inhibition of hydrogen peroxide turnover by SA was initially evaluated as
a function of salicylic acid, Figure 3.18. Interestingly, much smaller concentrations of SA
relative to CuBc were required to show inhibition of peroxide turnover.
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Figure 3.19 - titration of SA to 30 μM CuBc and 30 mM H2O2 in 100 mM pH 7.0 1:1
HEPES:MeOH

Michaelis-Menten parameters, shown in Table 3.2, were derived by fitting the
data from Figure 3.20. The overall data converging near the x-axis indicates more
noncompetitive inhibition character. Moreover, fitting Vmax,app/Km,app data as a function
of SA would not converge at the concentrations of SA being observed. Km,app
determination remained relatively constant through each titration of SA, each within
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the margins of error. This might indicate the competitive pathway would require a
much higher concentrations of SA as observed under aerobic conditions.
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Figure 3.20 – LB plot of inhibition of DTBC oxidation rate by SA as a function of H2O2
catalyzed by 10 μM CuBc with constant 2 mM DTBC in 100 mM HEPES:MeOH (1:1) at
pH 7.0 25.0 °C

Table 3.2 - MM parameters for SA inhibition against H2O2 activation for the oxidation
of 2 mM DTBC was titrated in the presence of 10 μM CuBc

SA (μM)
0.0
0.5

Vmax
(nM/sec)
489 ± 43
424 ± 102

Km (mM)
23 ± 6
26 ± 16

kcat
(sec—1)
(4.9 ± 0.2) × 10—2
(4.2 ± 1.0) × 10—2
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Catalytic Efficiency
(M—1 sec—1)
2.1 ± 0.6
1.6 ± 1.0

Table 3.2 cont.
2.0
4.0
16.0

408 ± 85
359 ± 40
270 ± 35

27 ± 14
29 ± 8
21 ± 8

(4.1 ± 0.8) × 10—2
(3.6 ± 0.4) × 10—2
(2.7 ± 0.3) × 10—2

1.5 ± 0.9
1.3 ± 0.4
1.3 ± 0.5

The uncompetitive dissociation constant for SA in the ternary, ESI, complex was
determined by fitting Vmax,app as a function of SA, Figure 3.21. Kiu for SA in the ternary
complex of SA-CuBc-O22— was determined to be 15 ± 3 μM. In this pathway SA
exhibited much stronger inhibition against H2O2 binding to the CuBc-DTBC complex
than its inhibition against DTBC binding to CuBc (Kiu = 5.24 mM).

Figure 3.21 – Vmax,app data fitted to Equation 2.5 as a function of inhibitor SA
concentration in determination of uncompetitive dissociation constant, Kiu
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2.1.3

Paramagnetic NMR

Co2+ has been extensively used as a paramagnetic probe for the investigation of
metal binding site in biomolecules by the use of NMR techniques given its similar
binding capabilities as Cu2+. To encourage binding in initial studies, the base
trimethylamine (TEA) was added at 1 equivalent to sodium salicylate to produce the
phenolate binding site to push equilibrium towards bidentate binding of SA. Studies of
the apo-SA were performed using a standard one 90° pulse followed by acquisition and
recycle delay using an 8000 Hz spectral window at 600 MHz. Studies including Co2+
used a presaturation pulse to reduce HDO intensity, allowing for more gain to be
applied to further resolve paramagnetic signals. Recycle times were much shorter, 250
ms, taking advantage of the short relaxation delays inherent to isotropically shifted
signals with a spectral window of 120 kHz.
Simple structure elucidation could be performed on the deprotonated salicylate
based on splitting and chemical shifts, which is in agreeance with previous studies of
SA signal assignments, Figure 3.22.
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Figure 3.22– 5 mM apo-salicylate in D2O (4.8 ppm) using a presaturation pulse sequence
at the HDO frequency

Upon addition of 0.8 equivalents of Co2+, the paramagnetically shifted signals at
57.2, 50.0, 31.7, and 11.1 ppm all indicative of salicylate bound to the Co2+ paramagnetic
metal, shown in Figure 3.23. Moreover the signals indicate binding through a bidentate
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mode, including the phenolate moiety for easy delocalization of the unpaired electrons
on the Co2+.

Figure 3.23 – 0.8 eq Co2+ salicylate in 10% D2O, with 1 stoichiometric equivalent of TEA
to include phenolate binding

Further elucidation using EXSY pulse sequence allowed for facile correlation of
paramagnetic signals with their diamagnetic counterparts, Figure 3.24. The EXSY
measures chemical exchange between isotropic signals with their diamagnetic
counterpart as the ligand undergoes association and dissociation with the metal center.
Using a modified NOESY pulse sequence, EXSY allows for correlation between two
signals are undergoing exchange between two states; in this case it is the bound and
unbound forms of the ligand.
The EXSY clearly reveals correlations for all four aromatic signals with the
salicylate ring. The paramagnetic signals along the F2 dimension clearly show
correlation to the diamagnetic counterparts along the F1 dimension. Expectedly, the
most downfield shifted signals, labeled D and C, are those that are closest to the
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deprotonated phenolate moiety, which would be closer to the paramagnetic Co2+ center
without the added carbon on the carboxylate binding site.

D

1H

label
A
B
C
D

C

A

B

Diamagnetic
Para(ppm)
magnetic(ppm)
7.68 (d)
31.7
6.79 (t)
11.1
7.30 (t)
50.0
6.81 (d)
57.2

Figure 3.24 – EXSY of salicylate with the addition of 0.2 equivalents of Co2+ with
salicylate in 10% D2O and signal assignments

Unfortunately, the ternary complex is not observable in D2O for the same reasons
a pure aqueous solution could not be used for kinetic studies: insolubility of the ternary
complex at a high concentration in the millimolar range for NMR studies. Binding of SA
to CuBc apparently makes the ternary complex as a whole much less polar and driving
insolubility of the ternary complex in aqueous solutions.
Challenges were still encountered with other solvents as well with solubility and
solvent interaction with the metal center was considered on choosing them. Solvents
like d3-MeOH proved even less soluble for concentrations of Bc >4 mM. d6-DMSO was
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ultimately used for subsequent investigations towards the ternary complex.
Unfortunately, a previous study had already determined that chemical exchange is
immeasurable between Co2+ and Bc in DMSO. Thus, EXSY NMR signal assignment
could not be properly performed using DMSO. Fortunately, this study was able to show
ternary molecular interactions through the secondary effects of signal disappearance
upon titration of SA.
In establishing a baseline for comparison, a control, the spectra in Figures 3.25 &
3.26 are comparable to a previous diamagnetic and paramagnetic studies.

Figure 3.25 – 1H NMR of 4 mM apo-bacitracin in d6-DMSO

Figure 3.26 – CoBc in d6-DMSO with 0.8 eq Co2+, using a presaturation pulse
sequence, diagmagnetic signal omitted for presentation of paramagnetic signals
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Upon addition of up to 4 equivalents of SA to Bc, most of the Bc signals appeared
unchanged other than small changes in chemical shift Figure 3.27. Signals at 16.1 and
13.2 ppm for the two Lys-6δ protons maintain intensity as SA increases, indicating the
stability of the nearby binding of the Glu-4 carboxylate. The thiazoline binding center of
Cys-2 appears to continue binding as SA was titrated. Based on previous signal
assignments the Cys-2β proton at 33.5 ppm is retained as are the adjacent Ile-1β and
Ile-1α protons at 46.5 and ~52.2 ppm, respectively. Their continued presence as SA was
titrated indicate the continued binding of the Cys-2 thiazoline ring. This likely indicates
the ‘tail’ portion of bacitracin binding while the ternary with SA complex is formed.
The disappearance of some signals imply that SA disrupts bonding of the His-10
residue. As signals at 13 and 36.5 ppm appeared unchanged, in comparison with
solvent signal, throughout the titration and were used as signal intensity references. As
Co2+ is bound via His-10ε nitrogen, the strong signal at 36.5 ppm was comparably
assigned to His-10δ proton from the aforementioned studies. Figure 3.27 shows an
apparent decrease in signal intensity for these signals potentially indicating interruption
of the Co2+-His-10 interaction after 1 equivalent of salicylate was added. The signal in
intensity is more apparent after the addition of the fourth equivalent. This is in
agreeance with the disappearance of the upfield shifted signal at —3.5 ppm which are
also assigned to the His-10β protons based on a TOCSY assignment of the region.25
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Figure 3.27 – Paramagnetic 1H NMR spectra of Co2+-bacitracin as SA is titrated by the
stoichiometric equivalent in d6-DMSO, where 1 equivalent is 10.2 mM and SA is 0.0 eq,
0.3 eq, 0.5 eq, 1.0 eq, and 4.0 eq (red) going down
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Figure 3.28 – diamagnetic region upon addition of SA to 10.2 mM CoBc in d6-DMSO.
Apo-Bc (top), and CoBc with the addition of 0.0 eq (green), 0.3 eq, 0.5 eq, 1.0 eq, and 4.0
eq (pink) SA going down

In support of salicylate interaction with the Co2+ center are two signals that show
an increase in intensity at 10.8 and 11.2 ppm, shown in Figure 3.27. A new signal at 10.8
ppm could indicate SA binding or formation of the ternary complex. Control studies of
SA in DMSO showed an approximate signal at 11.1 ppm for carboxylate γ proton on the
ring of SA. The increase in intensity of the signal at 16 ppm, shown in more detail in
Figure 3.29, might also indicate SA interaction. However, the assignment remains
ambiguous due to the overlapping Bc signal. Assuming the increase in intensity in
sharpening of the signal, this signal might be indicative of the β proton adjacent to the
carboxylate of SA. Confident assignment would require EXSY in a medium that
provides both exchange and solubility.
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Figure 3.29 – Focused 1H spectrum of 0.8 eq CoBc 0 SA (top) and 4 eq SA (bottom) in d6DMSO

Based on the addition of SA in DMSO to CoBc, some differences were observed
in the isotropically shifted signals. The sustaining paramagnetic chemical shifts of CoBc
with up to four equivalents of SA added indicate no chelation at these concentrations of
SA. Based on a comparison to prior CoBc spectra, it is likely that SA might be
disrupting the His-10 interaction with the metal center when SA is greater than one
equivalent. Assuming the binding pocket from the ring portion of Bc is interrupted by
SA, this would still leave space on the metal center for reactivity. Moreover, ligand
replacement rather than blocking of the binding site could explain why the Kic for SA is
so high under aerobic oxidative conditions.
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2.2 Thiabendazole Inhibition of CuBc Redox Activity

2.2.1

Kinetics

The history of thiabendazole and metal binding was established early in its
development.55 Tbz has shown up to 3-to-1 ligand-to-metal binding complexes revealed
in crystallographic studies.63 Cu2+ binding did not show any significant
spectrophotometric effects upon binding. It did, however, exhibit reduction in oxidative
activity of Cu2+ toward catechol oxidation as shown in Figure 3.30, suggesting Tbz can
block catechol from binding to and being oxidized by the metal center. Residual
oxidation after addition of one equivalent of Tbz to Cu2+ reveals open binding sites for
DTBC turnover. Subsequent titration of Tbz would likely show an oxidation rate
approaching zero, though, DTBC continues oxidizing at the concentrations of Tbz
observed in this experiment.
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Figure 3.30 – Tbz inhibition of 2 mM DTBC oxidation by 10 μM free Cu2+ in HEPES
buffer (pH 7.0) with 10% DMSO for catechol and Tbz solubility

Addition of Tbz to CuBc reveals a slightly different effect, shown in Figure 3.31.
Under aerobic conditions the rate of DTBC oxidation reduces as a Tbz increases. Larger
concentrations of Tbz were required to affect oxidation drastically, still showing
oxidation activity of CuBc in the presence of 100 equivalents of Tbz.
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Figure 3.31– oxidation rate of 2 mM DTBC upon addition of Tbz to 10 μM CuBc in 1:1
DMSO:HEPES 100 mM buffer at pH 7.0

In determining the type of inhibition towards DTBC turnover and the
appropriate dissociation constant(s) for Tbz towards CuBc, oxidation of DTBC
measured under varying amounts of Tbz, shown in Figure 3.32. Tbz showed more
mixed inhibition in the linearized plot, where convergence occurs at a point other than
the y- or x-axes. The data in Table 3.3 supports the conclusion of mixed-type inhibition
revealing a slight increase in Km,app and decreased turnover as a function of increasing
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amounts of Tbz. Based on the larger relative increase in kcat,app the Tbz inhibition shows
more uncompetitive character.

0.08
4.0 mM Tbz
2.0 mM Tbz
1.0 mM Tbz
0.1 mM Tbz
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Figure 3.32 – linearized LB plot for DTBC titrated to 100 μM CuBc in 100 mM pH 7.0 1:1
HEPES:DMSO where Tbz varied up to 4.0 mM

Table 3.3 – MM parameters determined by fitting the non-linearized data from Figure
3.32, where kcat and catalytic efficiency were determined using 100 μM CuBc

Tbz (mM)
0.0
0.1
1.0
4.0

Vmax
(nM/sec)
717.7 ± 19.0
552.4 ± 59.9
404.3 ± 22.5
269.7 ± 18.0

Km (mM)
4.46 ± 0.27
4.96 ± 1.17
4.77 ± 0.59
5.71 ± 0.79

kcat
(sec—1)
(7.2 ± 0.2) × 10—3
(5.5 ± 0.6) × 10—3
(4.0 ± 0.2) × 10—3
(2.7 ± 0.2) × 10—3
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Catalytic Efficiency
(M—1 sec—1)
1.61 ± 0.1
1.11 ± 0.3
0.85 ± 0.1
0.47 ± 0.1

Based on a likely mixed inhibition patter surmised from the Lineweaver-Burk
plot in Figure 3.32, dissociation constants Kic and Kiu were evaluated. Vmax,app/Km,app
from the MM parameters, Table 3.3, were evaluated as a function of SA concentration,
Equation 2.1. Kic was determined by fitting data from Table 3.3 to Equation 2.4, and
was found to be 1.1 ± 0.4 mM. Much like the SA inhibition of CuBc, Tbz required
relatively large amounts to inhibit oxidative turnover of DTBC in air.

Figure 3.33 – fitting for determination of Kic of Tbz towards CuBc under aerobic
conditions (R2 = 0.8) by fitting data from Table 3.3
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As Tbz is an inhibitor that exhibits strong binding in the presence of free-metal, the
relatively poor inhibition under aerobic conditions could be indicative of the physical
inaccessibility to form a stable ternary complexes with CuBc.
The inhibition constant for the for the ternary complex of Tbz-CuBc-DTBC (ESI)
was determined by fitting the Vmax,app as a function of Tbz concentration (Equation 2.5),
shown in Figure 3.34. The fitting yielded a constant Kiu of 1.5 ± 0.5 mM Tbz. The
relatively high dissociation constant could further indicate the lack of access for ligands
and substrates to bind around the Bc metal-binding pocket.

Figure 3.34 – fitting for determination of Kiu of Tbz towards CuBc under aerobic
conditions (R2 = 0.8) by fitting data from Table 3.3
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Much like examining the inhibition of SA towards peroxide turnover, similarly
Tbz was evaluated. Interactions between the three compounds may be instigated by
multi-antibiotic strategies used to control potential crop infections. Like Tbz, H2O2 can
be topically used on crops in concentrations as high 35% v/v, as advised by the USDA
and EPA in the United States; it is likely these concentrations are much lower upon
application after dilution.64,65 Upon titration of Tbz to CuBc in the presence of H2O2, the
rates of DTBC oxidation follow a complex pattern, shown in Figure 3.35. Substoichiometric titration of Tbz to CuBc in the presence of constant H2O2 and DTBC
showed a decrease in quinone production. When more than approximately one
equivalent of Tbz is added, an apparent increase in rate is observed until reaching an
equilibrium in rate. This pattern shows an obvious biphasic pathway for Tbz inhibition
in the presence of H2O2. One probable pathway is the chelation of copper from the Bc
active site. Given this was not observed in the aerobic case, it seems the hydrogen
peroxide in conjunction with Tbz might play a role in destabilizing the metal-Bc
interactions. In an effort to measure the Tbz inhibition against H2O2 toward CuBcmediated oxidation of DTBC, sub-stoichiometric concentrations of Tbz were used.
The rates of 2 mM DTBC oxidation by CuBc in the presence of increasing
amounts of H2O2 were measured at various amounts of Tbz, which allowed for
determination the inhibition pattern for Tbz against peroxide turnover, Figure 3.36.
Unlike previous titrations, this inhibition pattern could contain an equilibrium of a few
types of inhibition, potentially including chelation based on the previous figure. At the
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concentrations used, though, of Tbz it was still clear that Tbz was inhibiting DTBC
turnover via competitive and uncompetitive pathways based on the inhibition pattern
in Figure 3.36. This type of mixed inhibition pattern is evidenced by a lowering Vmax,app
and an increasing Km,app with an increasing amount of Tbz, as shown in Table 3.4.
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Figure 3.35 - titration of Tbz in the presence of 10 μM CuBc, 30 mM H2O2, and 2 mM
DTBC in 100 mM pH 7.0 1:1 HEPES:DMSO.

166

0.030
8.0
4.0
2.0
1.0
0.0

-1

1/Rate (nM sec)

0.025
0.020

M Tbz
M Tbz
M Tbz
M Tbz
M Tbz

0.015
0.010
0.005

0.000
-0.05
0.00

0.05

-0.005

0.10

0.15

0.20

0.25

1/[H2 O2 ] (mM-1 )

Figure 3.36 – LB plot for titration of hydrogen peroxide to 10 μM CuBc measuring
oxidation rate 3 mM DTBC with varying amounts of Tbz up to 8 μM.

Table 3.4 – MM parameters of hydrogen peroxide and 10 μM CuBc mediated turnover
in the presence of Tbz

Tbz (μM)
0.0
1.0
2.0
4.0
8.0

Vmax
(nM/sec)
497 ± 42
445 ± 48
383 ± 37
371 ± 37
345 ± 34

Km (mM)
28 ± 7
29 ± 9
31 ± 9
37 ± 10
39 ± 10

kcat
(sec—1)
(5.0 ± 0.4) × 10—2
(4.4 ± 0.5) × 10—2
(3.8 ± 0.4) × 10—2
(3.7 ± 0.4) × 10—2
(3.4 ± 0.3) × 10—2
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Catalytic Efficiency
(M—1 sec—1)
1.8 ± 0.3
1.53 ± 0.3
1.24 ± 0.3
1.00 ± 0.3
0.88 ± 0.3

Figure 3.37 – Fitting of Vmax,app/Km,app as a function of [Tbz] according to Equation 2.5
for 2.0 mM DTBC oxidation by the CuBc complex in the presence of increasing amounts
of H2O2 to afford the competitive dissociation constant, Kic.

The inhibition of hydrogen peroxide binding to the CuBc metal center was found
to have a Kic of 6.3 ± 0.7 μM for Tbz upon fitting of Vmax,app/Km,app as a function of Tbz
concentration, shown in Figure 3.37, to Equation 2.4. The Kic indicates a relatively
strong bonding towards the metal center, where affinity 1/Kic = 1.6 × 105 M—1.
Given the mixed inhibition exhibited in Figure 3.36, the apparent Vmax for each
concentration of Tbz was fitted to Equation 2.5, shown in Figure 3.38.
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Figure 3.38 - Fitting of Vmax,app as a function of [Tbz] according to Equation 2.5 for 2.0
mM DTBC oxidation by the CuBc complex in the presence of increasing amounts of
H2O2 to afford the uncompetitive dissociation constant, Kiu.

The fitting in Figure 3.38 revealed a Kiu 13.2 ± 2.6 μM for Tbz inhibition against H2O2.
Inhibition of the ternary complex exhibited a higher dissociation constant for ternary
complex. While much lower than the Kiu for SA, this could still be indicative of
difficulty for even small molecules to have the space to access the metal binding site or
different binding modes in Bc.
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2.2.2

Paramagnetic NMR

Paramagnetic NMR is able to determine structural information for the metal-Bc
complex in the presence of Tbz by measuring differences in the isotropically shifted
signals as Tbz was introduced to CoBc. Isotropically shifted signals of CoBc were
directly comparable to signal assignments performed by Tay, et al in d6-DMSO.19 As in
previous experiments, Co2+ was used as a paramagnetic probe in order to produce
observable paramagnetically shifted signals.
While signal assignment for Tbz binding was partially possible in d4-MeOD, with a
mix of broad and sharp paramagnetic signals based on proximity of paramagnetic
influence of proton relaxation. 2D exchange correlation in DMSO was not possible, due
in part to incredibly broad weak signals for Tbz, shown in Figure 3.39 (lower spectrum)
and/or lack of exchange. Bacitracin, Co2+, and Tbz required the more polar solvent,
DMSO, to maintain solubility, thus limiting 2D exchange data as observed by Tay, et al
and in these studies.19
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Figure 3.39 – Paramagnetic spectrum of Co-Tbz (0.9 molar equivalents Co2+) in d4MeOD (top) and d6-DMSO (bottom). Spectrum with DMSO zoomed 50k× relative to
diamagnetic region, acquired using a Super-WEFT sequence

Initial titrations of Tbz to CoBc revealed no new paramagnetic signals with up to
8 equivalents of Tbz. The lack of Tbz signals in ternary binding is likely due to the
broad weak signals observed in Tbz-Co2+ binding observed in Figure 3.39. Figure 3.40
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reveals a general weakening of most signals which likely indicates chelation of the
metal from bacitracin.

Figure 3.40 – titration of Tbz to 4 mM CoBc in d6-DMSO, where Tbz increased going
down: 0 Tbz (top, black), 0.5 eq Tbz (red), 1.0 eq (blue), 5.0 eq Tbz (orange), and 8.0 Tbz
(bottom, green). Best viewed in color for easy comparison
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In comparison with the kinetic data that revealed binding and inhibition, the ternary
complex is likely being formed at sub-stoichiometric concentrations, while higher
concentrations pushes the equilibrium towards the removal of the metal and formation
of the binary CoTbz complex. Alternatively, it might be performing stepwise ligand
removal of bacitracin that is not observed using the concentrations in this study.

III.

Concluding Remarks

The story of bacitracin is multifaceted given its presence in over-the-counter
antibiotics and in the soil as it is produced by a few Bacillus species. From the medicinal
perspective metallo-Bc and SA are both topical antibiotics. Based on the kinetic and
NMR data, the SA interaction might deem either compound less effective. The poor
binding by SA might make it less susceptible to inhibiting CuBc, or potentially ZnBc as
many of the over-the-counter form under aerobic conditions. SA seemed much more
effective at inhibiting DTBC oxidation in the presence of H2O2. The lower Kic and Kiu for
hydrogen peroxide indicates SA might effectively inhibit hydrogen peroxide turnover.
From the micro-ecological perspective, the inhibition of SA against CuBc might hold
some clues towards the chemistry in the soil and biofilms around plants like the willow
tree. SA in the soil could help regulate CuBc reactivity in the soil, helping maintain the
redox activity around the host organism. Extrapolating from the metal-binding and
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inhibition studies, SA could play a role in regulating other metallo-antibiotics and
metallo-biomolecules.
The study of Tbz also shows how metal-binding synthetic drugs can have an effect
on ambient metallo-antibiotics in the soil. Much like SA, Tbz is a topical antibiotic,
although, the organism to which it is applied are fruits and vegetables rather than the
scrapes and smalls skin wounds of people. Based on the data acquired in this
dissertation, Tbz might act a double-edged sword. On the one hand it protects plants
from fungal activity; and on the other hand, it might be at the sacrifice of the antibiotic
activity of bacitracin from ambient Bacillus. Moreover it might fine-tune the soil
microecological balance, and potentially may also sequester ambient metals in the soil.
Based on the strong metal-binding shown for Tbz likely plays a role in chelating
environmental and biological metals like Cu2+.
Whether the chemistry is occurring in the soil or on the skin, understanding the
chemistry of metal-based antibiotics ensure these interactions are taken into account
when they are present together. By observing the binding of SA and Tbz towards an
antibiotic metal center and inhibition of the metal center activity, this study helps
provide more information behind the chemistry occurring under medicinal and
microecological circumstances.

174

IV.

Materials and Methods

4.1 Kinetics

All chemicals were purchased from Sigma Aldrich. Kinetics experiments were
carried out using a Cary 50 UV-Vis spectrophotometer. Oxidation studies were
performed on 3,5-di-tert-butylcatechol, where the quinone formed was measured at 410
nm (ε410 = 1900 M—1 cm—1).
Kinetic experiments revealing SA inhibition were performed in a buffered mixed
solvent system to maintain pH and solubility of both the reactants and the products.
Ternary complexes were not soluble in 100% aqueous systems. 100 mM HEPES buffer at
pH 7.0 was mixed with an equal volume (1:1) of methanol.
Tbz inhibition studies were performed in a mixed solvent system as well, where
1:1 mixture of 100 mM HEPES at pH 7.0 and DMSO was used to maintain solubility and
pH control.

4.2 Nuclear Magnetic Resonance

All NMR studies were performed on an Agilent Inova and a Direct Drive
spectrometers at a reference proton resonance of 600 MHz. All samples were prepared
at ~5-10 mM in D2O, d6-DMSO, or d4-MeOD, as noted in the text. CoCl2 salt was used as
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a paramagnetic metal source to investigate metal binding. Its metal binding properties
reliably mimic Cu2+ binding in terms of binding geometry and motifs, while
maintaining smaller spectral windows <120 kHz. 1D 1H spectra were obtained by the
use of presaturation to reduce solvent intensity to better resolve the inherently weaker
paramagnetic 1H signals. Alternatively, “Super-WEFT” was also employed by taking
advantage of the fast relaxation of paramagnetic protons, wherein the delay times in the
pulse sequence (D1-180°-τ-90°) are optimized to reduce the diamagnetic signals in order
to comparatively improve the paramagnetic signals.66
NOESY and EXSY were the primary two dimensional NMR techniques employed to
determine the binding capabilities of Co2+ and the ternary complex including Co2+, Bc,
and SA. EXSY pulse sequences were modified based on the NOESY pulse sequence,
using short mixing time, rather than longer mixing times, to reduce NOE buildup
allowing only fast exchanging (1-20 ms) paramagnetic-diamagnetic protons to accrue
signal. Spectra were acquired with 120 kHz spectral windows, 64 scans, 512 increments,
10-20 Hz line broadening, and 1K×1K points in both dimension for processing.
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CHAPTER 4

Three-Dimensional Structure Elucidation of a Novel Peptide “Foldamer” and NMR
Evaluation of a Metallo-Peptoid
Adapted in part with permission from a Journal of the American Chemical Society
publication1

If you wish to make an apple pie from scratch, you must first invent the universe.
-

I.

Carl Sagan

Background

The importance of the development of non-resistant drugs cannot be understated! A
2013 Centers for Disease Control (CDC) study found approximately 20 million people
are infected by antibiotic resistance diseases, and 23,000 people die from them each
year! For individual patients this can be incredibly challenging as antimicrobial
resistance will invariably require more costly drugs, longer hospital stays, and loss of
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income. The overall cost of drugs, wage loss, hospitalization, and other peripheral costsof-care are estimated to be $35 billion in the U.S. alone each year.2
Antibiotic resistance is as old as antibiotics themselves. Natural antibiotics are
thought to have evolved as a means of self-preservation in a type of “arms race” for
microbes.3,4 This, of course, took place over billions of years of evolution and natural
selection for microbes to develop the antibiotics we observe and use today.
The ubiquity of bacteria makes human exposure to antibiotics inevitable. For
example, there is evidence of trace tetracyclines in nearly 2000 year old skeletal remains
from diets with high concentrations of the antibiotic.5 Most people, however, associate
antibiotic use with the last ~80 years. The introduction of antibiotics worldwide in the
1940s has inarguably saved millions of lives. Unfortunately, wide-spread, inconsistent,
and irresponsible use of antibiotics has led to many first generation drugs being no
longer effective towards disease. Many of the early and current generations of
antibiotics have suffered in efficacy due to mis-prescribing, such as prescribing an
antibiotic for viral infections, and patients not completing a cycle of a prescription
allowing for the more resistance bacteria to propagate resistance.2
Several approaches over the last several decades have been developed to curb
antibiotic resistance. The CDC and the World Health Organization (WHO) have
advocated with healthcare professionals and patients for responsible prescription of
antibiotics and to take antibiotics as prescribed, respectively.2,6 Carefully researched
studies have shown that some non-interacting drug combinations, or cocktails, can
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prove more effective and less prone towards developing resistance, even towards drug
resistant bacteria.7
Previous chapters have hopefully shown the structure of drugs and proteins can aid
in explaining their functionality. Many current methods similarly approach disease
control by designing structures that might induce a desired outcome. Some of the
primary considerations in drug design are specificity and efficacy.8 For example, if a
highly efficient drug is not specific towards its target, it could lead to unwanted sideeffects, injury, or death as the drug interacts with essential biological systems of a host
organism. Conversely, if the drug is highly specific towards a single, desired target, but
does not effectively perform or bind to the target, it will not be a desirable drug since it
would require high quantities to affect the target.
The development of new drugs can take several avenues of discovery, including
target-specific design, natural product isolation or synthesis, high-throughput
screening, and many others.8 The last couple of decades have had an influx of interest in
proteins and protein-mimics to treat disease. The predominant issue with protein or
peptides treatment for microbial disease is the relatively short bioavailability of most
exogenous peptides. Peptides introduced into biological systems often encounter
proteases that hydrolyze the foreign peptides, Figure 4.1.9 One of the common methods
to increase longevity of drugs is to alter the backbones to prevent protease recognition
and subsequent hydrolysis.
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Figure 4.1– Hydrolytic reaction performed by a protease along peptide backbone

Altering or designing peptides with non-standard backbones, other than L-α
configurations, have gained popularity for their increased in vivo longevity and for their
ability to mimic protein secondary and tertiary structures. Addition of one or two
carbons along the backbone to form beta- and gamma-peptides, respectively, have been
shown to have longer bioavailability.10-12 More complex combinations and backbone
structures, including the addition of bulky side groups and sulfono-peptides, are
discussed in the subsequent section.
Unfortunately, synthesis of mimetic peptides are not directly analogous to their
non-mimetic counterpart.13 Increased backbone length, allowing for more rotation
around a peptoid α-carbon, can change the structure and, thus, change the function of
the peptide.14 Drug design of peptido-mimetic structures can use strategies previously
developed by researchers studying non-mimetic counterparts, including target-specific
design and libraries of peptide variations for antibiotic screenings.15 Some studies, like
the one discussed herein, focus on developing three-dimensional structural motifs that
fold into specific patterns in order to maintain stability and potentially interact with
specific targets.1,16
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L-α-alanine

L-β-leucine

γ-aminobutyric acid

D-α-alanine

Figure 4.2 - Variations in peptide backbones via addition of carbons (second and third)
or inversion of stereo-center (last) compared to the most common natural peptide (first).

Many peptido-mimetic compounds have shown promise. Peptido-mimetic
compounds Lytixar™ and brilacidin are both currently in phase 2 trials for treating
Gram-positive bacterial infections and cancer, respectively.17,18 In another example,
specific folds were designed into the peptide, deemed foldamers, in order to bind to cell
membranes for eventual membrane depolarization. The cited small foldamer was even
shown to be efficacious towards multidrug resistant Staphylococcus aureus and
Escherichia coli.19
Two models for peptido-mimetic structure were explored in this dissertation. As
structure is indicative of function, as discussed in previous chapters, structural
information was ascertained using NMR. In the first study, a structural elucidation of a
novel D-sulfono-γ-AApeptide that can form a specific tertiary structure was performed.
A second study using a peptido-mimetic γ-peptoid was evaluated for its metal-binding

191

capabilities compared to its non-mimetic counterpart was structurally explored using
NMR.

II.

Results and Discussion

2.1 D-sulfono-γ-AApeptide/L-amino acid Structure and Conformation
Elucidation

In this study a novel peptide was synthesized using a variety of peptidomimetics motifs by Teng, et al. This particular peptide was designed to induce a specific
three dimensional folding pattern, making this peptide a “foldamer”. D-sulfono-γAApeptide/L-amino acid peptide was synthesized for its potential to fold into a helical
structure, based on previous literature.25
As opposed to the earlier studies discussed herein, this peptide does not contain
a metal center. In this case, it was included for its novelty and potential in drug design.
As discussed in chapter 1, many proteins like SOD1 require a flexibility in the scaffold
to modulate reactivity at the metal center. In understanding the design of threedimensional folding of peptide mimics, metallo-centers could be designed in future
developments with higher bioavailability and specificity. As metallo-antibiotics and
proteins have largely been disproportionately under-represented in research, by
including this study herein, it may help begin bridging the gap between peptido192

mimetics and metallo-peptides, which only more recent studies have begun
investigating.20-23
Published studies have previously shown the propensity for folding among
peptides containing the γ-backbone motif which has been further expanded by the Dsulfono-γ-AApeptide backbones.24,25 Moreover the N-acetylated-N-aminoethyl amino
acids (AApeptides) have shown potential for increased bioavailability by avoiding
proteolysis due to the lack of recognition sites required for proteolytic enzymes. As
study on these scaffolds have grown since their initial discovery, current designs are
also beginning to approach the efficiency of natural peptides.26,27 Figure 4.4 shows a
basic design scheme for these peptide motifs. These peptides use a combination Nsubstituted functional groups, like peptoids, lengthened backbones up to γ-carbons,
and the addition of bulky sulfono side-chains. For the initial four structures
synthesized, each peptide contained a repetition of L-α/D-sulfono-γ-AA amino acid, Lalanine, and a L-phenylalanine. Each sequence differed in combination of 3 or 4
repeating flexible amino acids, L-alanine and L-phenylalanine, and the presence of a
terminal L-alanine.

Figure 4.3 – Structural motifs for the design of D-sulfono-γ-AApeptide/L-amino acid
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For the purposes of using NMR as a technique to determine “foldamer”
properties, the peptide was synthesized maintaining the general scheme and length as
oligomer 3 in this publication. The peptide studied, oligomer 5, was synthesized using
slightly different sulfono- side chains and several amino side-groups to facilitate
accurate signal assignment, avoiding chemical shift overlap of repeating residues.
Oligomer 3 contained four repeating sulfono- side chains of para-chlorobenezene,
leading which would reveal NMR signal ambiguity due to overlapping chemical shifts,
especially for the internal amino acids. In the publication several similar oligomers of
varying length were studied using circular dichroism (CD) and X-ray crystallography to
elucidate three-dimensional folding in as much detail as possible. The synthesis of
oligomer 5 yielded the structure as shown in Figure 4.4.

Figure 4.4 – line representation of D-sulfono-γ-AApeptide/L-amino acid oligomer 5

Initial 1H NMR spectra were obtained using the water elimination (WET) solvent
suppression pulse sequence given the use of d3-MeOH solvent, which yields strong
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signals at 4.8 and 3.3 ppm, shown in Figure 4.5. Despite the relative simplicity of the
peptide, careful measurements of the gCOSY (gradient correlation spectroscopy) and
zTOCSY (total correlation spectroscopy) spectra were required to perform a complete
structural elucidation. In conjunction with the 1D 1H spectrum, the TOCSY allowed for
assignment of each amino acid residue based the number protons per residue and the
chemical shifts to make confident assignments. The TOCSY spectrum yields
information via long-range homonuclear scalar coupling. Longer times in mixing or
spinlock can achieve more through-bond coupling allowing for magnetization between
protons to show correlation up to several bonds from the irradiated signal. For example,
alanine would show three signals corresponding to one in the 7-9 ppm region, one
signal in ~2.5-4.5 ppm for the backbone proton, and a strong signal ~1-2 ppm for the CH3 side group. In comparison, a valine, such as residue 14, would yield five to six
signals in TOCSY corresponding to one proton in the NH region, one from the
backbone proton, and 3 or 4 from the side chain depending on any loss in symmetry of
the terminal CH3 groups due to any spin-coupling. Signal assignments for non-standard
amino acids proved more of a challenge since coupling across heteroatoms is unlikely to
occur, such as the sulfono- moiety. Measuring residues between heteroatoms loses
TOCSY correlation, relying on nuclear Overhauser effect spectroscopy (NOESY) to
perform longer range signal assignment for the adjacent residues, i+1 NOE. The i+1
assignments were predominantly observed for adjacent NH amide protons with Dsulfono-γ-AApeptide backbone protons. Overlaying TOCSY signal assignment with
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NOESY signal assignments aided in assigning signals for the D-sulfono-γ-AApeptide
side chains, as did the chemical shifts by using differing aromatic functional groups.
The complete signal assignment for the peptide is shown in Table 4.1 based on the data
gathered in Figure 4.5 and 4.6.

Figure 4.5 - full 1D 1H spectrum of 4.1 mM D-sulfono-γ-AApeptide/L-amino acid
oligomer 5 using WET solvent suppression pulse sequence using an Inova600
spectrometer, solvent signals at 3.3 and 4.8 ppm
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Figure 4.6– 1D 1H spectrum of D-sulfono-γ-AApeptide/L-amino acid with focus on
side chains (top), backbone CH groups (middle), and aromatic and backbone NH
groups (bottom)
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Figure 4.7– overlaid 2D spectra of D-sulfono-γ-AApeptide/L-amino acid in d6-DMSO,
followed by focus on the NH/aromatic correlations (f1 spectrum) to the side chain
correlations (f2 spectrum) (viewed best in color)
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Table 4.1 – complete signal assignment for oligomer 5 of D-sulfono-γ-AApeptide/Lamino acid

Residue
1

NH
8.05

2

8.19

3a

8.02

γ

β

α
4.27

Hβ'
1.33
1.72
1.86

4.35
4.26

2.92
3.39

4.00
3.97

7.64
8.74

5

8.47

6a
6b

2.89
3.33
1.43

4.75

4.14

3.12
3.21

4.31
3.91
3.82

8

8.36

9a

7.97

7.06

4.15

2.89
3.30

4.30

1.36

4.36

4.19

3.88
3.84

1.18

4.26

6.99
4.01
4.08
1.43

9b
10

8.94

11

7.91

12a

7.67

4.23

2.81
3.38

Hε'

Hζ'

1.64,
1.46

1.71,
1.64

2.93

NH2:
7.73, 7.75

7.37

7.43

7.63

OCH3:
3.82

7.41

7.74

7.92

7.03

7.80

7.01

CH3:
2.35
7.21,
7.26

1.13

7.87

7

Hδ'

1.18

3b
4

Hγ'

4.31
3.57
3.92

7.65
CH3:
1.18

7.93

1.16

12b

7.05

13

8.81

4.21

1.50

14

7.74

4.27

1.44

C-terminus

7.74

7.45
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7.79

CH3:
2.43

1.54

2CH3:
0.69,
0.77

Three-dimensional interactions and potential folding were determined using
several techniques, supported by NOE measurements. NOE interactions are
particularly useful in determining structural interactions as magnetization is transferred
via spin-lattice (through-space) relaxation. NOESY is limited by distance where signal
intensity is proportional to the inverse sixth power of the distance between the nuclei (I
α 1/r6); signal is limited by a 4-5 Å atomic distance through space depending on the size
of the molecule.
In terms of folding, particular interest was paid toward NOE signals pertaining
to nonadjacent residues. Seven i+2 (NOE signals two residues from NOE irradiated
proton) and two i+3 (three residues from the NOE irradiated proton) NOE signals. Of
particular interest are the two i+3 signals that are 17 bonds and 9 bonds away, Figure
4.8 and 4.9. The two i+3 signals reveal correlating interactions between the γ -proton of
residue 6b with the α-proton of residue 9b and the terminal methyl group of Lthreonine of residue 7 with the NH proton of residue 10. The relative weakness of the
signals signifies the upper limits of NOE interactions as their distances approach ~5 Å
in solution. These signals would not show correlation without organized folding of the
interior structure, similarly shown in previous studies of similar foldameric
compounds.25 The long time scales required for NMR obtains an average structure. The
ability to observe i+3 and multiple i+2 NOE interactions shows a relative stability this
structure at the timescales used for NMR.
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Figure 4.8 - i+3 NOE signal for 6aHγ and the backbone NH of residue 9a (signal
labeled).

Figure 4.9 – i+3 NOE signal for 7Hγ’ and the backbone NH of residue 10 (signal
labeled).

All of the NOE interactions can be summarized shown in Figure 4.10.
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Figure 4.10 – detected NOESY signals for i+1, i+2, and i+3 correlations. Best viewed in
color

In conjunction with crystal structures, and circular dichroism (CD) studies of the
similar oligomer 3, observed by Dr. Teng in this study, the i+2 and i+3 signal
correlations confirm an alpha helix conformation in methanol, shown in Figure 4.1 and
4.10. Crystal structure torsional angles of flexible backbone and the 16-16-14 hydrogen
bonding pattern also yield information on how NOE buildup could occur through
space by folding into the right handed π-helix secondary structure. This is further
shown as structural changes from the other 3 oligomers showed the same hydrogen
bonding pattern during crystallographic measurements. The secondary structure of
oligomer 5 would likely be akin to oligomer 3, as shown in Figure 4.9, proposed via
molecular dynamics calculations by Dr. Teng.1
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Figure 4.11 – D-sulfono-γ-AApeptide/L-amino acid proposed minimized structure for
oligomer 3

These de novo structures of the D-sulfono-γ-AApeptide with mixed with L-amino
acid residues reveals three-dimensional right-handed helical conformation. The
successful formation of a helical foldamer for D-sulfono-γ-AApeptide could provide a
synthetic scaffold for future oligomers. These motifs and structures could prove
invaluable during the development of bioavailable antimicrobials. Development of sidechains designed for hydrophobic membrane interaction could yield antimicrobial
activity via membrane depolarization as discussed in earlier studies while still
resembling the structures synthesized herein.8,9

2.2 Ac-FHFH γ-Peptoid and Peptide metal binding

Among an older class of peptido-mimetic compounds are the peptoids, poly-Nsubstituted amino acids. These poly-N-substituted peptides have been deemed
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‘peptoids’ by their creators, Reyna Simon et al in 1992.28 Similar to the β-peptides,
peptoids have the increased flexibility at the β-carbon as well as increased
bioavailability, having no natural proteolytic enzyme that can recognize this type of
backbone motif.29,30 Their uses are primarily in building peptide-like scaffolds using
side-chains on the backbone nitrogen rather than the α-carbon. Besides their use to
avoid proteolysis in drug design, they have also gained popularity to for their abilities
to form complex secondary structures due to the free-rotating β-carbon.

Peptide Ac-FHFH

Peptoid γ-AA-FHFH

Figure 4.12 – peptide and peptoid structures designed to probe difference in metal
binding

Most of the focus for peptoids has been on their structures as potential protein
mimics with only limited studies on using them as novel metal ligands. One of the
challenges in designing protein-like compounds are differences in specificity due to
structural changes. Peptoid-metal interaction studies are still relatively new with many
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studies published in the last couple years.22,23 Structural and reactivity modulation has
been shown for peptoid-based metallo-porphyrins, much like the native form!31,32 As
these novel class of peptides and peptoids continue to develop, the interactions and
chemistry they can perform in the presence of metals could yield much more stable,
reliable, and novel drugs. Only more recent studies have even started considering them
as potential targets for in metal-mediated neurodegenerative diseases, such as AD and
Parkinson’s disease.33 In understanding how peptoids might be inhibitory towards
diseases like AD, the structure and reactivity of metal-bound peptides were examined
in the following herein.
In this study a very simple peptide and peptoid model were synthesized using
standard solid-phase synthesis techniques. The sequences produced were the acetylated
Ac-FHFH with potential bi-dentate binding capacity in each compound. 1H NMR was
employed to probe metal bind capacities in the presence of paramagnetic Co2+ with
observable hyperfine shifts of ±100 ppm. As was the case for previously discussed
studies, protons closer to the metal binding sites experience isotropic shift due to
influence of the strong magnetic nature of the unpaired electron from Co2+.
Upon titration of one molar equivalent of Co2+ shows the isotropically shifted
signals for both the peptide and the γ-AA-peptoid, Figure 4.13. In the peptide
experiment (top spectrum) four broad signals appear signals at 55.2, 57.3, 66.5, and 70.4
ppm. This spectrum is comparable to the Mn-to-cobalt and Cu-to-cobalt substituted
MnSOD and azurin, respectively.34,35 Typically, ortho protons with reference to the
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coordination site on the imidazole ring would yield broader, less intense signals, if they
are visible. The more intense signals between ~40-90 ppm are typically indicative of
meta protons from the coordinated nitrogen. When Co2+ is bound to Nδ1, two meta
protons at CδH and Nε2H would be apparent.36a For a bidentate binding through the
delta nitrogen four signals would be apparent in this region, as shown in the Figure
4.13. Conversely for the peptoid, only two signals appear in this region at 65.8 and 44.6
ppm (bottom spectrum). The appearance of only two sharp signals likely indicates a
different binding mode through the Nε2. In the Nε2 metal coordination only the meta Nδ1
can be observed. Potentially, the ortho signals for the peptoid might also be apparent at
95.8 ppm given its far downfield shift and its broadness.

a

A caution to the reader: older texts could lead to confusion based on how some label

histidine. The approach I use is a more current labeling scheme, shown in Figure 4.13,
though, I do deviate from proper labeling of the peptoid with an additional carbon on
the side-chain to allow for easier comparison for both myself and the reader. Papers by
very well-respected chemists, like Ivano Bertini, Ph.D., are still very much correct in
their assignment, though, the scheme has been updated.
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Figure 4.13 – overlaid spectra for 4 mM Ac-FHFH (top) and γ-AA-FHFH (bottom) and 1
stoichiometric equivalent of Co2+, 50× zoom applied to γ-AA-FHFH far downfield
region signal.

In support for the tentative assignment of the peptoid bound to the ε2-nitrogen, a
drop of deuterated water was added to the NMR tube. Hydrogens on imidazole
nitrogens are prone to solvent exchange. Exchange from N-H to N-D would remove any
N-H signals. Figure 4.14 shows a drastic decrease in any signal intensity for both of the
apparent signals, confirming the Nε2-H coordination and signal assignment for the two
Nδ1 protons.
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Figure 4.14 – drop of deurated water added (top) to Ac-FHFH peptoid to confirm NH
signal assignment

The cause for the differences in the binding mode for the peptide and γAApeptide histidine residues, likely lies in the difference in the number of rotational
carbons for each residue. Each peptoid histidine residue contains three rotatable CH2
moieties over only 2 on the peptide. The extra rotation seems to play a role allowing for
different stable coordination site between binding motifs.
In many cases, solvation can also play a role in the folding and binding around metals.
In fact, solvation is often essential for protein functionality.37,38

208

Figure 4.15 – Line representation Ac-γ-FHFH binding Co2+ through Nε2

To determine how solvation or solvent polarity might be driving the influence of
the preferred binding motifs, d3-MeOH was added to each compound as shown in
Figures 4.16 and 4.17. In these experiments water was avoided due to the general
hydrophobicity of the phenylalanine residues.
In a comparison of the peptide and the peptoid, both show differences upon
addition of d3-MeOH. The peptide showed much more change in the chemical shifts.
Changes in chemical shift and intensity of two of the signals (using the diamagnetic
region as an intensity reference) decrease in intensity. This could potentially indicate a
change structural conformation or a potential weakening of the binding between the
metal and Nε.
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Figure 4.16 - 4 mM FHFH in d6-DMSO (top) and half d6-DMSO, half d3-MeOH (bottom)

Figure 4.17 – 4 mM γ-AA-FHFH peptoid in d6-DMSO (top) and half d6-DMSO, half d3MeOH (bottom)

In comparison, the peptoid chemical shifts show a general downfield shift while
approximately maintaining chemical shift difference. The more downfield shifted
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signals likely indicate a closer proximity to the metal center as the unpaired electron
from Co2+ influences the Nδ-H chemical shift more. Solvation in this case may not be
competing with imidazole binding or change in polarity of the solvent forces tighter
binding.
As peptoid-metal reactivity is still a mostly untapped resource in medicine, the
reactivity of the peptoid was also observed. In collaboration on this project with
Christian Tang, Ph.D., 1:1 Cu2+ and γ-AApeptoid were incubated with DTBC to
determine the redox activity of the metal center. Much like many of the previous Cu2+
redox centers, Cu2+ mediated oxidation of DTBC via O2 and H2O2 pathways yielding
intrinsic binding constants, Km,int, of 0.17 ± 0.02 mM and 23.5 mM towards DTBC and
H2O2, respectively. Secondary analysis using Hanes plots also revealed cooperativity
between both DTBC and H2O2 substrates.39 In terms of medicinal properties, this type of
reactivity would require tight regulation to avoid unnecessary and unwanted redox
activity. Scaffolds, as shown in the first half of this study, could provide more regulated
control of the active site and potentially a target.

III.

Concluding Remarks

The progress and sophistication of the peptidomimetic field has had a massive
growth over the last 30 years, though. The advent of many chemical techniques and
solid-phase syntheses have made once drugs impossible to produce, possible. Despite
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the rapid growth in the field, we are still learning and catching up to what nature had
millions of years to develop. Complex structures and intricate reaction pathways can
take years to develop. In developing novel methods for disease treatment, metals are
often overlooked. As the methodologies for peptidomimetics develop, metals could
play a role just as they do in nature: structural and/or reactive sites. The need for
understanding the role metal might play in reactivity is essential as shown in the second
half of the study. As the field develops more, three-dimensional folding motifs will be
essential for driving and modulating reactivity.

IV.

Materials and Methods

4.1 D-sulfono-γ-AApeptide/L-amino acid

Synthesis and purification of oligomers were performed by Teng, et al from the
aforementioned publication.1 NMR studies of oligomer 5 was performed using 5 mM
sample in d3-MeOH.
All NMR spectra were obtained on Varian 600 MHz magnet with an Inova600
console using VNMRJ to process all data using a WET pulse sequence to eliminate
residual solvent signal. All spectra were acquired with a 7k Hz spectral window using a
90° pulse width of 16 μs. The 1D spectrum was collected using 24k points with a 1.5 sec
delay for 32 scans. The f2×f1 dimensions were collected for 8k×8k points. The
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gDQFCOSY experiment was performed for 500 increments, 16 scans per increment,
using applying a 1.0 ms gradient pulse and 2.0 ms steady state pulses. zTOCSY was
performed using a mixing time of 80 ms with a DIPSI2 pulse pattern, 2.0 ms steady state
gradient pulses, and zero quantum filters calculated “on-the-fly” by VNMRJ at 30 and
40 ms. 32 scans were performed for 256 increments. To best visualize long-range NOE
coupling, 32 scans were performed for 500 increments with a mixing time of 200 ms. A
30 ms ZQ filter was used with a 2.0 ms steady state gradient pulse.

4.2 Peptide/Peptoid Ac-FHFH

Paramagnetic NMR spectra were performed on a Varian 600 MHz magnet with
an Inova console. All data were processed using VNMRJ 4.2. The superWEFT pulse
sequence was employed to minimize diamagnetic contribution to the receiver, allowing
for higher signal sensitivity of paramagnetic signals. The superWEFT pulse sequence is
a two-pulse sequence where first pulse is optimized for a 180°-90° tilt angle pulse,
followed by a short delay to allow paramagnetic proton relaxation, and finally a final
90° pulse (180°-τ-90°). Total sequence recycle times were 140 ms. A 130k Hz spectral
window was acquired using 16k data acquisition points. All samples were solvated in
d6-DMSO or d3-MeOH. Addition of water to determine N-H solvent exchangeability
was performed using 18.0 MΩ deionized water.
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Bioactivity. Copyright 2019. American Chemical Society.
Used with permission of Journal of Biological Chemistry, from Catechol oxidase-like
oxidation chemistry of the 1-20 and 1-16 fragments of Alzheimer’s diseaserelated β-amyloid peptide, Giordano F.Z. da Silva, Ph.D., William Tay, Ph.D.,
and Li-June Ming, Ph.D. 280, 17, 2005.

221

